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2. Summary 
For more than three decades, the increasing occurrence of infections caused by multiresistant 
bacteria has been the driving force for exploration of antimicrobial peptides (AMPs) as an 
alternative type of antibiotics. A large effort has been made in order to understand the 
relationship between structure/composition and activity (both antibacterial and cytotoxic) of the 
AMPs which are believed to interact with the bacterial membranes in an unspecific way (i.e. no 
target molecule). Literature suggests many structural parameters, which can explain the activity 
in some studies, but none of these have proved to be generally applicable for a given class of 
AMPs. This thesis presents our effort and results in obtaining a better understanding of the 
interaction between cationic α-helical AMPs (and peptidomimetics thereof) and membranes. 
The research is focused on structural studies of AMPs interacting with primarily DPC micelles as 
the membrane mimetic. Information regarding this interaction is obtained through standard 
NMR techniques and the use of paramagnetic relaxation enhancement, which yields information 
regarding the tilt, rotation, and insertion depth of the investigated peptides upon interaction 
with the membrane mimetic. 
These studies revealed the importance of side chain properties as well as the orientation of 
these relative to the overall structure and orientation of the peptide. It is shown how the side 
chains of some residues can bend towards their most favorable environment, while others 
cannot due to their position in the peptide sequence. It is also shown how alterations in peptide 
sequence can lead to extension and rotation of the helix. 
In a larger study of analogues of the short, cationic, and helical AMP, anoplin, correlations were 
sought between activity and the structural parameters: Hydrophobicity, hydrophobic 
moment/amphipathicity, charge, polar angle, rotation, tilt angle, and insertion depth. However, 
none of these proved useful for explaining the antibacterial activity, hemolytic activity or 
selectivity for the set of peptides. Correlations were only found when observing the 
hydrophobicity of the hydrophobic face and polarity of the hydrophilic face separately. An 
increase the hydrophobicity of the hydrophobic face increases the activity against all 
membranes: At low hydrophobicity no membrane activity is present, at moderate 
hydrophobicity decent activity against Gram-negative bacteria can be achieved, at higher 
hydrophobicity good activity can be achieved against both Gram-positive and Gram-negative 
bacteria while hemolytic activity becomes significant, and at high hydrophobicity the hemolytic 
activity becomes dominant which removes selectivity of the AMPs. Regarding the polarity of the 
hydrophilic face, an increase in polarity will increase the activity against especially Gram-
negative bacteria, while it appears that it does not influence selectivity of the AMPs. When 
utilizing the found correlations to optimize a longer peptide, it was found that the correlations 
hold true, but that the mean hydrophobicity of the hydrophobic face should be lowered in order 
to avoid strong hemolytic activity. Based on our findings, the usefulness of the structural 
parameters used in literature is discussed. 
The importance of side chain properties and their orientation was kept in mind during the 
interpretation of the solved peptidomimetic structures. When inserting a peptoid monomer into 
the helical AMP, maculatin-G15, an equilibrium between the cis and trans conformers was 
observed. This equilibrium was highly shifted, depending on the site of insertion of the 
hydrophobic peptoid monomer. For two of the analogues, only one conformer was observed 
and for one of the analogues the conformer was found to be the trans conformer. For the two 
other maculating-G15 analogues, an almost equal distribution between the cis and trans 
conformers was found. This led to a hypothesis that the backbone fold of the trans conformer 
might be energetically more favorable, and that the peptoid side chain properties plus site of 
insertion might be determining for the distribution of the cis and trans conformers.  
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3. Resume 
Igennem mere end tre artier har den stigende mængde infektioner, der er forårsaget af 
multiresistente bakterier, været den drivende kraft bag forskning i hvordan man kan anvende 
antimikrobielle peptider (AMPer) som et alternative til konventionel antibiotika. Inden for den 
gruppe af peptider der menes at interagere med bakteriemembraner på en uspecifik måde er 
der blevet gjort en stor indsats for at forstå hvordan peptidernes opbygning og struktur hænger 
sammen med deres antimikrobielle og hæmolytiske aktivitet. I den henseende er der blever 
foreslået mange strukturelle parametre i litteraturen som i de givne studier korrelerer med 
peptidernes aktivitet, men som ikke har vist sig at kunne forklare aktiviteten i andre studier med 
samme klasse af peptider. I denne tese præsenteres indsatsen i- og resultaterne fra vores 
arbejde med at opnå en bedre forståelse for interaktionen mellem kationiske α-heliske AMPer 
(og peptidlignende analoger) og membraner. Vores forskning har fokuseret på strukturelle 
studier af AMPer der interagerer med miceller dannet af primært DPC. Der er anvendt standard 
NMR teknikker såvel som paramagnetisk relaksationsforstærkning til at indhente informationer 
om hældning, rotation og indsættelsesdybde af peptiderne mens de er bundet til micellerne. 
Disse studier tydeliggjorde vigtigheden af sidekædernes egenskaber såvel som deres placering i 
forhold til den overordnede struktur or orientering af peptiderne. De viste hvordan nogle 
aminosyrers sidekæde kan bøje mod det miljø der giver den mest favorable interaktion, mens 
andres sidekæde ikke kan på grund af deres placering in peptid sekvensen. Studierne viste også 
hvordan substitutioner i peptidets sekvens kan forårsage rotation of forlængelse af dets heliks. 
I et større studie af analoger til det korte, kationiske og helikale AMP, anoplin, blev der søgt efter 
korrelationer mellem aktivitet og de strukturelle parametre: Hydrofobicitet, hydrofobe moment, 
ladning, polære vinkel, rotation, hældning og indsættelsesdybde. Ingen af disse parametre 
kunne dog forklare den antibakterielle aktivitet, hemolytiske aktivitet eller selektivitet for 
gruppen af peptider. Der blev kun fundet korrelationer når man enkeltvis betragtede 
hydrofobiciteten af den hydrofobe side og polariteten af den hydrofile side. Forøges 
hydrofobiciteten af den hydrofobe side forøges aktiviteten mod alle membraner. Ved lav 
hydrofobicitet opnås ingen membran aktivitet. Ved moderat hydrofobicitet kan der opnås god 
aktivitet mod Gram-negative bakterier. Ved højere hydrofobicitet kan der opnås god aktivitet 
mod både Gram-positive og Gram-negative bakterier men der vil også være betydelig 
hæmolytisk aktivitet. Ved høj hydrofobicitet vil den hæmolytiske aktivitet blive dominerende og 
al selektivitet vil forsvinde for AMPerne. Angående polariteten af den hydrofile side vil en 
forøgelse i polaritet forøge activiteten mod specielt Gram-negative bakterier, imens det ser ud til 
at selektiviteten ikke bliver påvirket. Ved at anvende disse korrelationer til at optimere 
aktiviteten af et længere peptid blev det eftervist at korrelationerne er alment gældende, men 
forsøgene vist også at den gennemsnitlige hydrofobicitet af den hydrofobe side skal reduceres i 
takt med at længden af AMPet forøges for at undgå stærk hæmolytisk aktivitet. Baseret på disse 
resultater er brugbarheden af de forskellige strukturelle parametre blever diskuteret. 
vigtigheden af sidekædernes egenskaber og placering blev inddraget i fortolkningen af de løste 
peptidlignende strukturer. Når en peptoid monomer indsættes i det helikale AMP, maculatin-
G15, se en ligevægt mellem cis- og trans konformerer. Denne ligevægt forskydes kraftigt alt 
afhængigt af hvor peptoid monomeren indsættes. For to af analogerne kan kun en af 
konformererne observeres, og for den ene af disse analgoer blev det bevist at det var trans 
konformeren. For de to andre maculatin-G15 analoger blev der fundet en næsten ligelig 
fordeling af cis- og trans konformererne. Dette ledte til en hypotese om at peptidernes foldning 
af rygraden er energimæssigt mest favorabel for trans konformeren, og at peptoid monomerens 
sidekæde egenskaber og indsættelses sted er afgørende for fordelingen mellem cis- og trans 
konformererne. 
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5. Abbreviations and 
Nomenclature 
Amino acids are abbreviated to three or four letters because of the extensive use of non-classic 
amino acids. Peptide analogues are named by the way they differ from the wild type molecule 
with classic amino acids abbreviated to one letter and non-classic amino acids abbreviated to 
three or four letters as follows: The anoplin analogue 8K is anoplin where residue 8 is 
substituted to Lys, and 4Orn is anoplin where residue 4 is substituted with the non-classic amino 
acid ornithine. 
 
Citations in the articles refer to only the reference list at the end of that article. Citations in the 
thesis refer to the reference list at the end of the thesis. 
 
AMP: antimicrobial peptide 
Aoc: L- 2-amino octanoic acid 
BCA: bicinchoninic acid 
βNal: β-2-naphthylalanine 
CCA: α-cyano-4-hydroxycinnamic acid 
CD: circular dichroism 
Cha: β-cyclohexylalanine  
cmc: critical micelle concentration 
CFU: colony forming units 
COSY: correlation spectroscopy 
Dab: 2,4-diaminobutyric acid 
Dap: 2,3-diaminopropionic acid 
DIC/DIPCDI: N,N´-diisopropylcarbodiimide 
DIEA: N,N-diisopropylethylamine 
DPC: dodecyl phosphocholine 
EC50: effective concentration at which 50% of the red blood cells are lysed 
Epa: 2-amino,3-ethylpentanoic acid 
Fmoc: fluorenylmethyloxycarbonyl chloride 
Gd(DTPA-BMA): Gadolinium diethylenetriaminepentaacetic acid bismethylamide 
HATU: N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridine-1-yelmethylene]-N-
methylmethanaminium hexafluoro-phosphate N-oxide 
HOAt: 1-hydroxy-7-aza-benxotriazole  
Hle: homoleucine 
HPLC: high-performance liquid chromatography 
Hser: Homoserine 
HSQC: heteronuclear single quantum coherence 
MALDI: matrix-assisted laser desorption ionization 
MBC: minimum bacteriocidal concentration 
MIC: minimum inhibitory concentration 
MS: mass spectrometry 
Nle: norleucine 
Nleu: [(2-methylpropyl)amino]acetic acid 
NMP: N-methyl-2-pyrrolidone  
NMR: nuclear magnetic resonance 
NOE: nuclear Overhauser effect 
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NOESY: nuclear Overhauser effect spectroscopy 
Nva: norvaline 
O-Me-Ser: O-methyl-serine 
Orn: Ornithine 
PBS: phosphate buffered saline 
PLS: partial least squares 
PRE: paramagnetic relaxation enhancement 
QSAR: quantitative structure-activity relationship 
RMSD: root mean square deviation 
SAR: structure-activity relationship 
SDS: sodium dodecyl sulfate 
TFA: trifluoroacetic acid 
TFE: triflouroethanol 
TIS: triisopropyl silane 
TOCSY: total correlation spectroscopy 
TOF: time of flight  
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6. Introduction 
During the last few decades, a vast amount of research has been conducted on elucidating the 
structure-activity relationships (SARs) of antimicrobial peptides (AMPs)1–5. AMPs have been 
deemed as one of the most promising classes of molecules for development of new 
antibiotics1,2,6. This is due to the fact that they have always existed as part of the innate immune 
system, without causing development of significant resistance mechanisms in the invading 
pathogens1,6–8. The goals of the SAR research are to understand the biochemical interactions of 
AMPs with microbes, and to be able to make rational designs of AMPs instead of producing huge 
combinatorial libraries, which are both costly and labor intensive8.  
In general, AMPs can be divided into classes based on which organism they have been isolated 
from; mammalian defensins9, plant defensins10, and bacteriocidins11. Furthermore, AMPs are 
normally also categorized based on their biophysical characteristics, where the major distinction 
is whether they are cationic or anionic AMPs. The group of cationic AMPs is significantly larger 
than the anionic group12,13. Finally, AMPs are also categorized based on their structural 
characteristics into α-, β-, αβ-, non-αβ-, and θ-defensins (cyclic AMPs)8,14. 
 
As of May 2014, the amount of AMPs reported in the antimicrobial peptide database13 is 2407, 
and of these, 2106 are cationic. A search based on their structural characteristics reveals that 
the major group of AMPs is the cationic α-helical peptides with a total of 311 entries (many of 
the entries have not been structurally investigated). Approximately half of these AMPs have 
been isolated from amphibians and insects13. 
 
In general, AMPs can have both a direct antimicrobial effect and have the ability to activate the 
adaptive immune system15. When only considering the direct antimicrobial effect, many 
different mechanisms of action have been proposed for AMPs, but, in general, AMPs are either 
membrane interacting or membrane penetrating. The membrane interacting AMPs are believed 
to either cause lysis of the cells through pore formation/dissolution of the membrane or to bind 
to the membrane or a membrane component (both specific lipids and proteins) in a way that 
prevents normal function of the cell6,16.The membrane penetrating AMPs are proposed to 
interact with an intracellular target, which in most cases has been proposed to be DNA6,17. A 
recent review of the proposed mechanisms of action has been made by Nguyen et al.18. 
 
The cationic α-helical peptides (one of the major groups of AMPs) are generally characterized as 
having an extended structure in solution, but forming an amphipathic helix upon interaction 
with phospholipid membranes6,17. However, reports have also been made of compounds that 
appear to adapt a globally amphiphilic distribution of its residues without the formation of a 
secondary structure upon interaction with membranes19. Many SAR studies have been 
performed on the cationic α-helical AMPs in order to increase their activity against 
microorganisms and/or reduce their toxicity towards human cells. 
Parameters used for evaluation of AMP potency 
Normally, the studies evaluate the potency of the AMPs by using the minimum inhibitory 
concentration (MIC) of the peptide in vitro, i.e. the peptide concentration which is required to 
prevent microbial growth in a selected media. However, in some studies also the minimum 
bacteriocidal concentration (MBC) is used instead of the MIC. In many studies, the aim has been 
to obtain more potent analogues in order to use lower amount of drugs for a treatment. 
However, many of these potent analogues have also showed a high hemolytic activity which in 
turn increases the health risks. The hemolytic activity is often measured as an EC50 value, which 
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is the concentration of peptide required to lyse 50% of the red blood cells in vitro. In the end, it 
is the combination of the antimicrobial and hemolytic activities which determines whether an 
AMP is a good candidate to become an antimicrobial drug. The aim is to obtain a high specificity, 
i.e. a high ratio of EC50/MIC, and this ratio has been termed the therapeutic index or selectivity 
index. For a good AMP, the EC50 value is high and the MIC value is low, and thus a good 
therapeutic index is high. It should be noted that the absolute value of the therapeutic index 
varies depending on the method of choice (for instance the initial amount of CFU in the 
microorganism suspension used for the experiments.  
Structural parameters used to explain activity and selectivity of 
AMPs 
The structural parameters which have been investigated in order to obtain more potent AMPs 
include; charge, hydrophobicity, hydrophobic moment/amphipathicity, helicity, and polar 
angle1,2,6,17,20. 
 
The charge of the cationic α-helical peptides normally lies in the range of +2 to +9 and is 
believed to be responsible for the initial electrostatic attraction to the negatively charged 
phospholipid membranes of the microorganisms17. Mutation studies have shown that there is a 
correlation between increased charge and increased antimicrobial activity and selective toxicity 
towards microorganisms2,5. However, this correlation is not always found21, and increasing the 
charge above a certain amount can reduce the antimicrobial activity and increase the toxicity 
towards host cells5. 
The hydrophobicity of a peptide is estimated in several ways in the literature. It is sometimes 
defined as the percentage of hydrophobic residues within a peptide, and is normally in the range 
of 40-50%8,17. The hydrophobicity can also be defined as the sum of the hydrophobicity of each 
residue in the peptide (several different hydrophobicity scales are used, which yield distinct 
values for a given peptide22–27). In order to be able to compare the hydrophobicity between 
peptides of different length, the mean hydrophobicity has been introduced, which is simply the 
sum of the hydrophobicity of each residue divided by the number of residues2,28. Another 
suggested parameter regarding the hydrophobicity is the sum of the residual hydrophobicities of 
the hydrophobic helix surface5. 
The hydrophobicity is essential for the interaction between the AMP and a membrane, but for all 
definitions of hydrophobicity presented here, an increased level of hydrophobicity is strongly 
correlated with increased toxicity towards mammalian cells and thus loss of specificity1,2,5,8,17,29. 
The composition of amino acids in known AMPs has been plotted against the AMP classification 
as either antibacterial, anticancer, antifungal, antiviral, or toxic towards mammalian cells8. It 
shows that the AMPs that are toxic towards mammalian cells are characterized as having the 
highest degree of hydrophobicity. In order to reduce the toxicity of AMPs to mammalian cells, 
the hydrophobicity should be reduced to below 50% hydrophobic residues8. 
The hydrophobic moment of a helical AMP is used as a quantitative measurement for its 
amphipathicity17 and is calculated as the vectorial sum of the individual amino acid 
hydrophobicities, normalized to an ideal helix24,30. Like with the hydrophobicity of AMPs, an 
increased hydrophobic moment has been found to correlate strongly with an increased activity 
against mammalian cells and thus, a reduced specificity1,3. 
The helicity of peptides is the percentage of α-helical content in the secondary structure, 
predicted on the basis of circular dichroism (CD) measurements. Helicity has been determined 
both in solutions containing the helix inducer, triflouroethanol (TFE), and in detergents such as 
SDS2,21. From studies including helicity as a parameter, it has been found that increased helicity 
can increase the antimicrobial activity of an AMP, but it increases the toxicity toward cells 
composed of neutral phospholipids even more1,2,20. 
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The polar angle 
Based on the distributions of the amino acids in the helical wheel model, the polar angle has 
been defined as the angle which spans the hydrophilic residues plus half the distance from the 
outermost hydrophilic residue to the first hydrophobic residue on each side. This parameter has 
also been investigated in relation to AMPs activity and selectivity, and it has been found that a 
reduced polar angle (i.e. larger hydrophobic face of the helix) increases the activity of some 
AMPs3,4,31. 
Quantitative structure-activity relationships 
A different approach on how to develop AMPs with superior abilities was initiated in the 1980’s, 
where continuous physico-chemical properties of the 20 amino acids were described32. This 
property data matrix was soon after extended and subjected to principal component analysis, 
from which 3 principal properties were derived. These 3 descriptors were then successfully used 
in a partial least squares (PLS) regression analysis in order to determine quantitative structure-
activity relationships (QSARs) between peptides and their activities33. 
Later on, this principle has found widespread use34–39, and even descriptors for non-naturally 
occurring amino acid have been derived40.  
 
The initial derivation of QSARs and the prediction of more potent peptide analogues had some 
downsides, as information about sequence and secondary structure was not implemented in the 
amino acid descriptors. Thus, the derived QSARs only yielded information about the general 
content of amino acids in a peptide32–34. This caused researchers to include peptide descriptors 
such as helicity (as determined by circular dichroism), hydrophobicity (not percentage of 
hydrophobic residues but the sum of the hydrophobicities of all residues), and charge together 
with the amino acid descriptors, which resulted in improved prediction abilities34. More recently, 
the inclusion of the interaction between residue neighbors has successfully been included in the 
PLS modeling36, and predictions by the use of neural networks have also been presented41. 
Motivation for this work 
Despite all the mutation studies and all the QSAR investigations, the molecular changes which 
result in increased or decreased antimicrobial activity and specificity have not yet been 
understood41. Already in 1992, Bessalle et al. stated that parameters such as helicity and 
amphipathicity are rather indirect, and that information regarding the actual structures of AMPs 
and their association with bacteria is needed21. Almost a decade later, Giangaspero et al. stated 
that the interrelationships between size, sequence, charge, helicity, overall hydrophobicity, 
amphipathicity, angles subtended by hydrophobic and hydrophilic faces are a key to understand 
how AMPs function, but that these interrelationships are often not taken into account in SAR 
studies2. 
 
We, too, believe that the key to understanding the function of AMPs lies within the molecular 
interaction between the AMP and the bacterial membrane, and that a more detailed knowledge 
about this interaction is needed in order to rationally design the optimal AMP based on a given 
lead structure.  
Paramagnetic relaxation enhancement 
Recent advances within nuclear magnetic resonance (NMR) spectroscopy have made it possible 
to obtain very accurate and detailed structural data regarding the interaction between a peptide 
and a membrane mimic. This is done by determining the insertion depth of individual atoms  
17
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(e.g. each Hα) of the peptide in micelles consisting of the widely accepted membrane mimic 
dodecylphosphocholine (DPC)42,43.  
 
Paramagnetic relaxation enhancement (PRE) is commonly used in NMR to obtain long-range 
distance information which is very helpful when determining the tertiary structure of large 
proteins. The closer a paramagnetic agent is to an excited nucleus, the faster the nucleus will 
return to its equilibrium state. Thus, by measuring the signal intensities at different time points, 
the relaxation rate of each atom can be measured and converted to relative distances to the 
paramagnetic agent. 
In our technique, this principle is used by adding chelated Gd ions to the NMR samples 
containing AMPs bound to DPC micelles. The Gd complex, Gd(DTPA-BMA), has been found not 
to interact with either DPC or peptides and to be bulky enough not to be able to reach the 
interior of a DPC micelle. Thus, the experimental conditions can be considered to consist of a 
DPC micelle with one or more helical AMPs inserted into the micelle surface and surrounded by 
water and Gd(DTPA-BMA) complexes, as illustrated in Figure 6.1. 
 
 
Figure 6.1: Illustration of how the paramagnetic agents influence the relaxation of the different H
α
 of the peptide 
with different magnitudes. 
 
As illustrated by the thickness of the lines between the Gd(DTPA-BMA) complexes and the 
peptide backbone, the part of the AMP which is exposed to the water will experience a strong 
relaxation enhancement while the parts buried in the micelle interior will experience a weaker 
relaxation enhancement. The only atoms of the peptide which can be used for these calculations 
are the ones which do not exhibit hydrogen exchange (thus ruling out many HN). However, due 
to the side chain flexibility the insertion depth accuracy decreases the further away from the 
backbone a hydrogen is located, and thus only the Hα atoms are used. This allows for the most 
well defined orientation of the peptide backbone relative to the micelle interior. 
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7. Aim and content of this work 
The overall aim of this work has been to use PRE to study in detail the interaction between 
helical AMPs and DPC micelles (membrane mimic) and through this explain how the different 
structural parameters correlate with their antimicrobial and hemolytic activity. In addition, PRE 
is used to study the structural consequences of implementing a peptoid monomer into a helical 
AMP (insertion of peptoid monomers increases the proteolytic stability of a given AMP). 
 
This work was initially conducted on analogues of the cationic helical AMP Anoplin, but 
regarding the peptidomimetics the major part of the work has been conducted on analogues of 
the cationic helical AMP maculatin. Each of these studies has resulted in a separate manuscript 
to be submitted. 
However, some of the work was not appropriate to include into these publications, and thus a 
section has been included in this thesis containing further results and discussion of these. 
 
Based on the new knowledge obtained during this study, I reexamined various SAR parameters 
used in literature to understand, how they arose and how useful they really are. This has 
resulted in a section containing a discussion of commonly used SAR parameters in the light of 
the results presented in this thesis. 
Finally, the major conclusions of this thesis are given together with my thoughts about further 
research, changes in methodology, and prospects for future application of PRE in relation to the 
work of AMPs and peptidomimetics presented in this thesis.  
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Rational Design of alpha-helical antimicrobial 
peptides – DOs and DON’Ts 
Lars Erik Uggerhøj[a], Tanja Juul Poulsen[a], Jens Kristian Munk[b], 
Marlene Fredborg[c], Teis Esben Sondergaard[a], Niels Frimodt-
Moller[d], Paul Robert Hansen[b], Reinhard Wimmer*[a] 
Antimicrobial peptides (AMPs) are promising candidates to battle multiresistant bacteria. Despite extensive research, 
structure-activity relationships of AMPs are not fully understood, and there is a lack of structural data of AMPs in lipids. 
Here, we present the NMR structure of anoplin (GLLKRIKTLL-NH2) in micellar environment. A vast library of substitutions 
was designed and tested for antimicrobial and hemolytic activity as well as changes in structure and lipid interactions. This 
showed that improvement of antimicrobial activity without concomitant introduction of strong hemolytic activity can be 
achieved by subtle increases in the hydrophobicity of the hydrophobic face or subtle increases in the polarity of the 
hydrophilic face of the helix, or – most efficiently – a combination of both. Based on the results, a set of guidelines are 
given on how to modify cationic α-helical AMPs in order to control activity and selectivity. The guidelines are finally tested 
on a different peptide. 
 
Introduction 
Since the discovery of penicillin, the occurrence of 
infections by drug resistant bacteria has become more 
and more frequent. Today, the development of bacterial 
resistance towards the known antibiotics has become 
an extensive problem, and there have even been 
examples of infections by bacteria which are resistant 
to all approved antibiotics.[1] In an attempt to obtain new 
drugs for treating multiresistant bacterial infections, a 
vast amount of research has been conducted regarding 
AMPs. This effort has been going on for more than 
three decades, but as of now, only a few AMPs have 
been approved for use; ambicin (nisin – a food 
additive), polymyxin B and E (last-resort antibiotic due 
to its heavy side effects), and gramicidin S (topical 
treatment of wounds).[2] Much of the work regarding 
AMPs has been focused on understanding how to 
make potent AMPs with little toxicity towards the host 
cells. A major class of AMPs is the cationic helical 
peptides,[3] which are the focus of this work. 
Many of the older studies regarding the cationic 
helical AMPs introduced structural parameters 
(hydrophobicity, charge, hydrophobic 
moment/amphipathicity, angle of hydrophobic and 
hydrophilic face, and helicity), which were useful for 
explaining the observed difference in antibacterial 
activity and in some cases cytotoxicity.[4–8] However, 
none of these parameters were sufficient for making a 
general guideline on how to improve antibacterial 
activity without causing increased cytotoxicity. In later 
been suggested that this is because of the parameters 
being interconnected:[9] e.g. an increase in charge or 
hydrophobicity will result in an altered amphipathicity. 
It is now known that increases in charge and 
hydrophobicity in general increase antibacterial activity, 
but that both can increase cytotoxicity, this goes 
especially for hydrophobicity.[5,7,10] Is has also been 
shown that an increase in hydrophobicity will result in a 
larger increase in activity against Gram-positive 
bacteria compared to Gram-negative bacteria.[5,11] 
Helicity is believed to correlate with the cytotoxicity of 
the AMPs, but helicity is often measured by circular 
dichroism (CD) in solutions of trifluoroethanol (TFE) 
which is a helix-inducing solvent.[9] The helicities 
obtained from such experiments are not directly 
comparable to the degree of helicity that will be induced 
in the AMPs upon interaction with actual membranes. 
In some of the later research, great care has been 
taken to keep certain parameters constant while 
varying one or two other parameters, and the actual 
interaction of a given AMP with the membrane has 
been taken into consideration. Here, a principle called 
the “snorkel effect” has been considered, which states 
that the insertion of a peptide is dependent on the side 
chain length of the polar residues. The long aliphatic 
side chains of Arg and Lys thus allow the peptide to be 
deeper inserted into the membrane while the side chain 
[a] L. E. Uggerhøj, T. J. Poulsen, Dr. T. E. Sondergaard, Prof.. R. 
Wimmer 
Department of Biotechnology, Chemistry, and Environmental 
Engineering 
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charge is still able to interact with the lipid head groups 
on the surface.[9] 
Despite a vast amount of data, the structure-activity 
relationship of cationic helical AMPs is still not fully 
understood, and a generally applicable set of 
guidelines on how to increase AMP activity while 
retaining or improving selectivity has not yet been 
achieved. 
Unlike many other studies, we approach the 
development of structure-activity relationships by 
including experimentally determined high-resolution 
structures of peptides bound to micelles into the study, 
because we think that a key to understanding SAR of 
AMPs is the interaction between peptides and lipids. 
For this study, we focus on the simplest helical 
AMP found to date, anoplin, isolated from the venom 
sack of the solitary spider wasp, Anoplius samariensis. 
Anoplin is a decapeptide AMP, GLLKRIKTLL-NH2, 
amidated at the C-terminus. It has an extended 
conformation in water, but upon binding to membrane 
mimics it folds into (at least partly) an alpha helix.[12] 
The actual structure of the peptide has not previously 
been published. The activity for anoplin and derivatives 
thereof has been reported in several sources, where 
the most frequently used strain is E.coli ATCC 
25922.[12–17] However, the reported MIC values are not 
consistent for this peptide, which gives rise to some 
concern about how active this peptide really is.  
This work is a continuation of previous studies on 
anoplin.[13,14] Initially an Ala scan conducted on anoplin 
showed that increased activity resulted from insertion of 
Ala in positions 5 and 8.[13] This was further explored by 
insertion of strongly hydrophobic aromatic amino acids 
in these positions. The analogues 5W (Trp inserted in 
position 5 of anoplin), 5F8W, and 5K8W all showed a 
significant increase in antibacterial activity, but also an 
increase in hemolytic activity. For 5W and 5F8W this 
increase in haemolytic activity is so high, that the 
analogues lose their selectivity.[13,14]  
The onset of this work was to structurally study 
anoplin together with the analogues 5W, 5F8W, and 
5K8W in order to find an explanation for their 
differences in antibacterial and haemolytic activity. This 
culminated in three successive studies. Firstly, a 
structural study, utilizing a recently developed NMR 
technique for studying the actual orientation and 
insertion depth of peptides into micelles,[18] was 
performed on the selected anoplin analogues. These 
results showed structural differences in the interaction 
between the peptide and the DPC micelle of the three 
anoplin analogues. This gave rise to a hypothesis 
explaining the activities of the three analogues 
compared to anoplin. Secondly, a larger set of peptides 
was designed using conservative substitutions in order 
to investigate how the separate modulation of 
hydrophobicity of the hydrophobic face and polarity of 
the hydrophilic face influenced the activity of anoplin. It 
was also investigated how these changes affected the 
insertion depth of selected analogues into the DPC 
micelle. Thirdly, the found correlations between 
structure and activity of the anoplin analogues were 
used to design two optimized anoplin analogues as well 
as to design optimsed analogues of a different helical 
AMP, citropin. This verified that the discovered 
correlations could be used for rational design and that 
they apply to other helical AMPs as well.  
The two optimized anoplin analogues proved to be 
the most active and selective analogues of anoplin 
found to date and confirm our theories regarding how to 
optimize the activity and selectivity of cationic α-helical 
AMPs. The optimized citropin analogues also supports 
our theories, but showed that hydrophobicity per turn of 
the helix must be reduced for longer peptides in order 
to maintain selectivity of the AMPs. Both the improved 
anoplin and citropin analogues showed broad spectrum 
activity, and high activity against two multiresistant 
bacterial strains. In conclusion we present a list of what 
to do and what not to do when attempting to improve 
the activity of a cationic α-helical AMPs.   
Results and Discussion 
Results are presented in three parts: 
Part 1 describes the structure ensembles of anoplin, 
5W, 5K8W, and 5F8W and compares the observations 
with previous publications on the structure of anoplin. 
The structural behavior of these analogues upon 
insertion into DPC micelles is then discussed, leading 
to a hypothesis on two different types of polar residues 
in α-helical AMPs.  
  
Part 2 describes all results related to the antibacterial 
and hemolytic activity of anoplin and its analogues. 
This part also includes the results of our structural 
studies of selected analogues, as well as our 
hypothesis, which explains their activities through 
various structural parameters. 
 
Part 3 describes how the findings from part 2 are used 
in designing optimized analogues of anoplin and 
citropin, and what was discovered from this small set of 
peptides. 
Part 1: Structural analysis 
The structures of anoplin, 5W, 5F8W, and 5K8W were 
solved in the presence of DPC micelles using classical 
NOE constraints (see Figure S1), Talos derived angle 
restraints, and weighted PRE-derived distance 
restraints to the micelle center. Subsequently the 
structure ensembles were energy minimized in a DPC 
micelle surrounded by water. 
anoplin GLLKRIKTLL-NH2 
5W GLLKWIKTLL-NH2 
5F8W GLLKFIKWLL-NH2 
5K8W GLLKKIKWLL-NH2 
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The refined structures have been submitted to the 
Protein Data Bank Japan (PDB) (anoplin: 2MJQ, 5W: 
MJR, 5K8W: 2MJS, 5F8W: 2MJT). Statistics for the 
structure ensembles can be found in Table S2.  
Helical content of anoplin 
All 4 peptides folded into a regular α-helix for 
residues 2-10 plus the C-terminal amide and featured a 
flexible N-terminal glycine residue, as exemplified by 
anoplin in Figure 1. This high degree of helicity is in 
contradiction with the helical content of anoplin 
reported in literature from CD measurements: Between 
32% and 77% in membrane mimicking solvents (up to 
50% TFE or 8.5mM sodium dodecyl sulfate 
(SDS)).[12,13,19] As stated in the introduction, and 
supported by Zelezetsky et al.[9], the helicities obtained 
in solutions of TFE are not comparable to the degree of 
helicity that will be induced upon interaction with actual 
membranes. SDS has a critical micelle concentration 
(cmc) of 8.5mM (dependent on salt concentration). 
Thus, under the conditions reported in the literature, 
there was no or only very small amount of micelles 
present. In our NMR samples, the concentration of 
DPC is more than 100 times its cmc. This difference in 
experimental conditions might explain why complete 
helices are observed in our study and not in previous 
publications. The use of TFE and submicellar SDS 
concentrations will not represent the actual degree of 
helicity a peptide will adopt upon binding to a lipid 
membrane. However, the low helicities obtained from 
CD might also be caused by the method itself, as CD is 
known to have limited sensitivity for short helical 
sequences[15]. In any case, the NOE data on anoplin 
and the three analogues provide clear evidence for the 
presence of an α-helix ranging from residue 2 to 10 
(Figure S1). 
 
Figure 1. Structures in the final ensemble of anoplin. A: 
Comparison of the backbone of all 20 structures shows very little 
variation, except for the terminal residues “N” and “C” denote the N- 
and C-termini of the peptide, respectively. B: Illustration of the 
flexibility of the side chains and their orientation relative to the helix. 
Residue numbers are labeled. C: Illustration of the location of the 
first three structures of the anoplin ensemble in the interface 
between the micelle and the surrounding water. It is noteworthy 
that the nitrogen atoms of Arg 5, Lys 7, and the N-terminus are 
located close to the phosphate groups of the lipids. The illustration 
has been made with a water accessible surface using YASARA 
[20]
. 
Peptide insertion into DPC micelle 
The determined insertion depth profiles of anoplin, 5W, 
5F8W, and 5K8W are shown in Figure 2. The insertion 
depth values for each Hα are listed in Table S3 along 
with their standard deviations. The insertion depth 
profile is very similar for anoplin, 5W, and 5K8W. There 
is a variation in the insertion depth of the N-terminus 
(residues 2 and 3) with anoplin being the least inserted 
followed by 5K8W and then 5W, which correlates with 
the increasing hydrophobicity of these analogues. The 
variation in position 5 of these three peptides shows 
that Lys5 is less deeply and Trp5 is more deeply 
inserted than Arg5. However, these changes are 
approximately of the same size as the experimental 
uncertainties (RMSD limits shown in Table S3), and 
should be interpreted with caution. On the other hand, 
5F8W has a significantly different insertion depth 
profile, which shows this analogue is oriented quite 
differently in the micelle. Furthermore, 5F8W is 
significantly deeper inserted than the other analogues. 
  
Figure 2. Insertion depth profiles of anoplin and the three 
analogues 5W, 5K8W and 5F8W, showing the distance of each H
α
 
from the micelle center. The micelle radius is ≈22.7 Å. When 
comparing the influence of the 5W mutation, the overall insertion 
depth profile is conserved except for residue 5. There is a slightly 
deeper insertion of Leu2 and Leu3 in the 5W analog, but their 
insertion depth relative to each other is conserved. For 5K8W, the 
substitution from Thr8 to Trp has not altered structure and micelle 
interaction at the C-terminus at all. The mutation from Arg5 to Lys 
only resulted in a slightly lesser insertion of H
α
 5. The insertion 
depth profile of the double mutation 5F8W is significantly different 
from the others: 5F8W is deeper inserted into the membrane, and 
the changes in the insertion depth profile correspond to a rotation 
around the helical axis. 
To visualize the differences in insertion of the 
peptides into the membrane mimetic, a geometrical 
analysis was performed on the refined structure 
ensembles. Here, the angle of the geometric center of 
each side chain relative to the direction to the micelle 
center were determined and used to draw the helical 
wheel plots of the four AMPs shown in Figure 3. 
The helical wheel projection of anoplin corresponds 
well with the helical wheel model except for a slight 
compression of the hydrophobic face (the hydrophobic 
side chains are moved closer to each other than 
expected from the helical wheel projection). For 5W, a 
slight clockwise rotation of the N-terminal part of the 
helix is seen, while the Trp side chain is oriented much 
closer to the membrane interior compared to the 
direction in the standard helical wheel. For 5F8W, the 
whole helix has been rotated about 30° clockwise and 
Trp8 side chain is likewise bent towards the membrane 
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interior. For 5K8W, the orientation of all side chains 
corresponds to the standard helical wheel.  
 
Figure 3. Helical wheel projections based on experimental data 
together with the standard helical wheel projection of anoplin. The 
arrows represent the direction from the micelle center to the 
geometric mean of each side chain. The plots are oriented in a way 
that the direction towards the micelle center is down (defined as 
0°), i.e. Ile6 of anoplin points directly towards the micelle center. 
The grid with small labels shows the angle of rotation relative to the 
micelle center. Hydrophilic side chains are illustrated by red arrows, 
and hydrophobic side chains are illustrated with blue arrows. No 
experimental data regarding the insertion depth of Gly1 could be 
obtained, and the structure ensembles show that Gly1 is highly 
disordered for all analogues. Thus, Gly1 has not been included in 
the helical wheel projections. 
All of these observations can be explained by the 
fact that a given side chain will orient itself in the 
direction which reduces the total energy of the system 
to its minimum. In anoplin, the side chains are grouped 
closer together on the hydrophobic face, which can be 
caused by either a slight extension of the helix or by a 
bending of the hydrophobic side chains in order for 
them to be more directly inserted into the micelle 
interior. For 5W, the Trp residue is bent significantly 
towards the interior of the micelle with a resulting twist 
of the backbone for residues 2-5. This indicates that the 
insertion of the Trp side chain into the hydrophobic 
interior of the micelle is so favorable that a small 
distortion of the backbone is of less importance. When 
looking at the standard helical wheel of anoplin, one 
might have assumed that the substitution of residue 5 
from charged to hydrophobic side chain would cause a 
rotation of the whole peptide, in order for the 
hydrophobic face to point directly into the micelle. 
However, the experimental data show that this is not 
the case. It is not possible for a single substitution to 
influence the structure of the helix beyond the turn of 
which it is embedded in (assuming a reasonable high 
amphipathicity of each turn). Thus, only residues 2-5 
are influenced on the backbone level, and only by a 
small amount, whereas the remaining residues are still 
locked completely in position by the strongly 
amphipathic motif of anoplin. Almost all the structural 
change is restricted to the orientation of the side chain. 
For 5F8W, the rotation of the whole helix allows the 
now hydrophobic residues 5 and 8 to be located closer 
to the micelle interior relative to the two remaining 
charged residues. Like for 5W, this analogue also show 
a bending of the Trp side chain towards the micelle 
interior, although it is not as significant as for 5W. In 
this peptide, both turns of the helix have had a 
substitution on the same side of the helix, which is why 
there is now a rotation of the whole molecule as 
opposed to the 5W analogue. In Figure 4, the change 
in orientation of Trp in 5W and 5F8W can be seen 
relative to the orientation of the corresponding side 
chain in anoplin.  
 
Figure 4. A: Structure ensembles of anoplin and 5W inserted into a 
spheric model of a membrane with a radius of 22.7Å, where only 
the side chains of residue 5 are displayed. This shows how the 
change in side chain 5 orientation of 5W, schematically shown in 
Figure 3, affects its orientation relative to Arg5 and the micelle 
surface. B: Structure ensembles of anoplin and 5F8W inserted into 
a spheric model of a membrane with a radius of 22.7Å, where only 
the side chains of residue 8 are displayed. This shows how the 
rotation of 5F8W and bending of the Trp 8 side chain affects its 
orientation relative to Thr8 and the micelle surface. 
In 5K8W, Trp is inserted on the right hand side of 
the second turn of the helix (in the projection). Here, it 
is oriented further towards the bulk water phase 
compared to the other two analogues with Trp. In this 
position neither rotation nor bending of the side chain 
takes place. The structure of this analogue shows that  
residue 8 is too far away from the micelle interior for it 
to be able to bend and reach the micelle interior and 
through that obtain a more energetically favored 
configuration. When comparing this with the 
observation from the structural ensemble of anoplin, 
where residue 5 and 7 were often found in close 
proximity of a lipid head group and that residue 4 and 8 
were primarily pointing directly into the solvent, it 
appears that there are two different types of the 
hydrophilic residues in these AMPs: in each turn of the 
helix, one of the hydrophilic side chains is primarily 
interacting with the membrane, whereas the other 
primarily interacts with the solvent. 
An important result from this study is that there is a 
significant deviation between the theoretical helical 
wheels of the peptides  and their actual helical wheel 
projections. This effect is quite clear, despite the fact 
that the α-helix of anoplin only consists of three turns. It 
could well be imagined that this effect becomes more 
significant with increasing length of the helix. Thus, 
care should be taken, when using the helical wheel 
model to design optimized analogues. 
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Part 2: Antimicrobial and hemolytic activity studies 
In order to understand how the activity of anoplin 
correlates with its structure and physiochemical 
properties, we designed a stringent set of peptides, 
where only one parameter was modified at a time. This 
set of analogues was made by only performing 
conservative substitutions, where charge, polarity, and 
chain length at the hydrophilic face and hydrophobicity 
and branching at the hydrophobic face were modified. 
Based on the structural studies already described, we 
ensured to keep a positive charge in position 5 and 7, 
in order to not disrupt their interaction with the lipid 
head groups. Furthermore, we did not perform 
modifications on the central residue of the hydrophobic 
face (Ile6). 
Due to the discrepancies in the reported MIC data 
of anoplin[12–14], we revised the standard methodology 
related to the activity assays in order to ensure the 
reliability of our data. Peptide synthesis, purification, 
and validation were done according the standard 
procedures as described in the methods section. 
Regarding concentration determination, we discarded 
the standard procedures as they either depend on 
100% completion of chemical reactions (amino acid 
analysis, Bradford, modified Lowry, and bicinchoninic 
acid (BCA)) or a compatible amino acid composition 
with the standard protein sample (Bradford, modified 
Lowry, bicinchoninic acid (BCA), and UV/Vis). 
Weighing of the peptides was also discarded due to 
insufficient knowledge regarding the amount of 
remaining counterions from the chromatographic 
purification. For anoplin (four positive charges), the 
presence of four trifluoroacetate ions would account for 
40% of the weight. We decided to use quantitative 
NMR with triflouroethanol (TFE) as an internal 
standard. This allows for the quantification of 
trifluoroacetate by 19F-NMR in addition to quantifying 
the peptide by 1H-NMR. Furthermore, TFE can easily 
be removed by lyophilisation. We mainly compared the 
peaks of Hε (CH2 group) of Lys and H
δ of Arg residues 
and the peaks for the CH2 group in TFE, which was our 
internal standard. These peaks proved to be very well 
separated in the 1D spectrum as shown in Figure S4. 
For the determination of antimicrobial activity we have 
included an activity study using an oCelloScope for real 
time optical measuring[21] in addition to the standard 
broth micro-dilution assay[22]. The oCelloScope allows 
for a semi-continous microscopic monitoring of the 
bacterial cells, thus enabling the identification of 
irregularities during the assay. In order to enable 
comparison of our activity data with previously reported 
activity values of anoplin analogues, the whole set of 
peptides were tested against the most frequently used 
bacterial strain in anoplin studies, E.coli ATCC 
25922.Testing of the hemolytic activity was performed 
using the standard procedures as described in the 
methods section. 
The antibacterial and hemolytic activity of the whole 
set of anoplin analogues is shown in Table S5, while 
the subsets of analogues used for the discussion are 
shown in Tables 1-5. The full names of the non-classic 
amino acids are given in the abbreviation list, and their 
structures are shown in Figure S6. 
MIC value of anoplin 
The MIC value of anoplin was measured to be 100μM 
(the tested concentrations were 75μM, 100μM, and 
150μM) against 5x105 CFU/mL of E.coli ATCC 25922. 
This value is twice as high as the reported MIC value 
for anoplin at low salt concentration against 1x105 
CFU/mL[12]. Our experimental conditions are very 
similar to those of Konno et al.[12], except for the initial 
concentration of bacteria. Small studies were 
performed to investigate the importance of bacterial 
growth phase and initial bacterial concentration on the 
measured MIC values. It was found that only the initial 
bacterial concentration influenced the MIC value: each 
dilution of bacterial concentration by a factor of 5 
(1.25x107, 2.5x106, 5x105, 1x105 CFU/mL), reduced the 
MIC value by a factor of 2. Based on this, our activity 
value for anoplin is in complete agreement with those 
published in the first paper of anoplin[12]. 
Substitutions on the hydrophilic face 
When increasing the polarity in position 4 by 
rearrangement of side chain atoms, shortening of side 
chain, and increase in charge, a general increase in 
antimicrobial activity is observed (Table 1). An increase 
in activity is not observed for every single modification, 
but it is highly plausible that the changes in activity 
occur, which are smaller than the concentrations steps 
used in the MIC assay. The only exception for this 
trend is 4Dap, but this might be caused by the ability of 
the charge on the side chain of Dap to interact with the 
backbone[23]. Thus, this amino acid should not be used 
in the design of AMPs. Based on these results, the 
presence of a charge in position 4 is not essential for 
maintaining the activity, but the residue should be 
highly polar. However, the presence of a charge in 
position 8 is very important, while the less drastic 
increase in polarity to 8S did not show a measurable 
effect. The change from Arg to Lys in position 5 did not 
result in a measurable change in antimicrobial activity. 
The 4,8Dab analogue illustrates the combined effect of 
using charged residues with a reduced chain length 
(increased polarity compared to Lys). It features an 8-
fold increase in activity compared to anoplin, yet 
without introducing hemolytic activity within the range of 
concentrations tested (≤500μM). 
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Table 1. Activities of anoplin analogues with substitutions on the 
hydrophilic face. 
 MIC 
[μM] 
EC50 
[μM] 
Selectivity 
(EC50/MIC) 
Hydrophobicity 
4T 200 >500 >2.5 7.12 
4Hser 150 >500 >3.3 ~7.12
[a]
 
4S 100 >500 >5 6.82 
Anoplin 100 >500 >5 5.87 
4Orn 100 >500 >5 5.75 
8S 100 >500 >5 5.57 
4Dab 75 >500 >6.7 5.52 
4Dap 100 >500 >5 5.26 
5K8K 25 >500 >20 4.64 
8K 25 >500 >20 4.62 
4,8Dab 12.5 >500 >40 3.92 
[a] The hydrophobicity is estimated by extrapolation of the loss or 
gain in hydrophobicity upon removing or adding a CH2 group to a 
functionally identical side chain. 
This improved activity upon increasing the polarity 
of the hydrophilic face by adding a charge to position 8 
(8K) and shortening of the side chains in position 4 and 
8 (4,8Dab) is intriguing. Is position 8 more prone to 
interact with lipid head groups compared to residue 4? 
Does the shortening of these side chains increase the 
possibility for these residues to interact with lipid head 
groups? Based on the structural studies in part 1 of this 
study, we estimated that residues 4 and 8 were 
primarily solvent interacting. If this is true, does the 
charge then create a better interaction with the solvent? 
Or does the increased charge increase the efficiency of 
the peptide in reaching the lipid part of the bacterial 
membrane? 
In an attempt to find an answer to these questions, 
the structures and insertion depth profiles of 4Orn, 
4Dab, 4Dap, and 8K were determined and compared to 
anoplin. In Figure 5, it can be seen how a decrease in 
chain length of residue 4 causes the peptide to be less 
deeply inserted in that turn of the helix. Going from the 
anoplin to 4Dap, the insertion depth of residue 4 
changes with about 1.5Å and becomes very similar in 
insertion depth to Thr8. The analogue 8K is slightly 
deeper inserted than anoplin and 4Orn. Previous 
studies have considered the so-called snorkel effect, 
where the length of the polar side chains is believed to 
influence the insertion depth of the helix.[9] The 
observations in our data confirm this theory: The longer 
the side chains are on the hydrophilic face, the deeper 
the AMP can be inserted. In our data, we can only state 
this for the two solvent interacting residues, as we do 
not have data on analogues with shorter chain lengths 
of residues 5 and 7. The insertion depth data does, 
however, not correlate with the antimicrobial activity of 
the analogues. EC50 was not measurable for any of 
these analogues. 
 
Figure 5. Insertion depth profiles of 4Orn, 4Dab, 4Dap, anoplin, and 
8K, showing the distance of each H
α
 from the micelle center. The 
micelle radius is ≈22.7 Å. It shows that the decrease in chain length 
of residue 4 gradually pulls residue 4 and 5 further out of the 
micelle, and that for 4Dap this even influences the insertion depth 
of the whole molecule. Furthermore, the increase in chain length in 
position 8 allows for a deeper insertion of the peptide, especially 
around residues 4 and 5. 
The refined structures and helical wheel projections 
of these analogues did not yield an explanation for their 
differences in antimicrobial activity. In this respect, it 
can be debated whether the DPC micelles are an 
appropriate model system for the negatively charged 
bacterial membrane of E.coli, and whether the use of a 
more accurate model system would reveal an 
explanation for their activities. 
The fact is that the zwitterionic nature of the DPC 
micelles resembles the surface charge of human cells 
more than that of the negatively charged bacterial cell 
membranes. Thus, DPC micelles are not the ideal 
model system. However: DPC is available in 
deuterated form, and it forms relatively small 
aggregates to keep transverse nuclear magnetic 
relaxation from becoming too fast. SDS would fulfil 
those criteria, too, and have a negative charge, but 
previous experiments have shown that the PRE-based 
method for determining insertion depths does not yield 
reliable results with SDS micelles. In order to obtain 
further understanding of the interaction of these AMPs 
with membranes, further developments in solution state 
NMR compatible membrane mimics are required. 
In the end, we can conclude that an increased 
polarity of the hydrophilic face of anoplin increases its 
antimicrobial activity against E.coli, but not conclude 
why. 
Substitutions on the hydrophobic face 
As stated in the introduction, an increase in 
hydrophobicity of a compound is often associated with 
enhanced antimicrobial- and hemolytic activity, the 
latter being enhanced the most. Our results show that 
anoplin is no exception, however, our careful tuning of 
hydrophobicity allows for a more detailed view on this. 
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The hydrophobic face of the helix was altered 
conservatively by gradually increasing or decreasing 
hydrophobicity of the two ends of the peptide (residues 
2, 3, 9, and 10). The amino acids used to substiute the 
Leu residues were (O-Me-Ser)-Val-Met-Nva-Leu-Nle-
Epa-Hle-Aoc-Cha-βNal, listed by increasing 
hydrophobicity. The resulting 2,10 and 2,3,9,10 series 
presented in Table 2 show that even a slight reduction 
in hydrophobicity removes membrane activity, while an 
increase in hydrophobicity increases both antibacterial 
and hemolytic activity. Any increase in hydrophobicity 
compared to the wild type, save for 2,10Epa, results in 
a measurable hemolytic activity (EC50 drops below 
500μM). For the 2,10 series, it can be seen that the 
hemolytic activity increases much more steeply than 
the antibacterial activity after the 2,10Hle analogue 
(two- to threefold reduction in selectivity). It is also 
interesting to notice the increase in both antibacterial 
and hemolytic activity when going from the branched 
2,10Epa analogue to the longer and less branched 
2,10Hle analog, which have equal hydrophobicities. A 
similar trend is not observed when going from anoplin 
(Leu) to the linear Nle analogues which also have equal 
hydrophobicities. The 2,10Hle analogue is the most 
selective of the anoplin analogues with substitutions in 
both ends of the peptide. It should be noted that 
anoplin, 2,10Nle, and 2,10Epa might have a higher 
selectivity, but it could not be determined due to the 
very low hemolytic activities. Based on this, we can 
conclude that the hydrophobicity of the hydrophobic 
face is essential for the selectivity of anoplin, and this is 
probably valid for other cationic α-helical AMPs as well. 
 
Table 2. Activities of anoplin analogues with substitutions of the 
hydrophobic face. 
 MIC 
[μM] 
EC50 
[μM] 
Selectivity 
(EC50/MIC) 
Hydrophobicity
[e]
 
2,10 substitutions series 
2,10(O-Me-
Ser) 
>200 >500 - ~2.29
[a]
 
2,10V >200 >500 - 4.91 
2,10M >200 500 <2.5 4.93 
2,10Nva >200 >500 - 5.21 
Anoplin 100 >500 >5 5.87 
2,10Nle 100 >500 >5 5.87 
2,10Epa 50 >500 >10 ~6.57
[a]
 
2,10Hle 12.5 380 30.4 ~6.57 
2,10Aoc 6.25 71 11.4 ~7.27
[a]
 
2,10Cha 6.25 100 16 7.91 
2,3,9,10 substitution series 
2,3,9,10(O-
Me-Ser) 
>200 >500 - ~0.11
[a]
 
2,3,9,10V >200 >500 - 3.95 
2,3,9,10M >200 >500 - 3.99 
2,3,9,10Nva >200 >500 - 4.55 
Anoplin 100 >500 >5 5.87 
2,3,9,10Nle 100 >500 >5 5.87 
2,3,9,10Hle 12.5 125 10 ~7.27
[a]
 
2,3,9,10Aoc
[b]
 - 20 - ~8.67
[a]
 
[a] The hydrophobicity is estimated by extrapolation of the loss or 
gain in hydrophobicity upon removing or adding a CH2 group to a 
functionally identical side chain. [b] Sample could not have its MIC 
value measured reliably due to poor solubility. 
The question is then: How should the 
hydrophobicity of the hydrophobic face be increased in 
order to obtain the best selectivity? The results in Table 
2 demonstrate an interesting feature of the anoplin 
analogues regarding this. When comparing 2,10Hle 
with 2,3,9,10Hle, no change in antibacterial activity is 
observed, while a threefold increase in hemolytic 
activity occurs. An approximate threefold increase in 
hemolytic activity is also observed when going from 
2,10Aoc to 2,3,9,10Aoc, but here the MIC value could 
not be determined reliably, due to aggregates in the 
solution during the assay (this was only detected by 
inclusion of the oCelloScope measurements). The 
further increase in hydrophobicity by also increasing 
the size of residues 3 and 9 does not benefit the 
antibacterial activity but significantly increases the 
hemolytic activity and the tendency of the peptides to 
form aggregates (maybe self-aggregates). This trend is 
supported by our set of single substitutions presented 
in Table 3. 
 
Table 3. Activities of anoplin analogues with single substitutions on 
the hydrophobic face which increases the hydrophobicity. 
 MIC 
[μM] 
EC50 
[μM] 
Selectivity 
(EC50/MIC) 
Hydrophobicity 
Anoplin 100 >500 >5 5.87 
2Cha 25 500 20 6.89 
10Cha 12.5 350 28 6.89 
2(βNal) 6.25 300 48 7.25 
[a] The hydrophobicity is estimated by extrapolation of the loss or 
gain in hydrophobicity upon removing or adding a CH2 group to a 
functionally identical side chain. 
This series of peptides also demonstrates the 
correlation between hydrophobicity and membrane 
activity discussed for the 2,10 and 2,3,9,10 series. 
However, this series also demonstrates that the effect 
on peptide activity depends on the site of modification, 
as seen by comparing 2Cha with 10Cha. When 
comparing 2Cha and 10Cha with 2,10Cha, it can be 
seen that the single substitutions exhibit better 
selectivities. 2(βNal) supports this trend, as its 
hydrophobicity is comparable to that of 2,10Aoc and 
2,3,9,10Hle but displays a three- to fivefold higher 
selectivity, respectively. 
These observations lead us to the conclusion that 
an increase in hydrophobicity on the hydrophobic face 
of the helix should not be divided equally on each turn 
of an AMP, as this increases the general membrane 
affinity of the whole peptide and makes it unselective 
through increased hemolytic activity. This is 
substantiated by the findings of Slootweg et al.[17], 
where the Lipophilic amino acid derivative ((S)-2-
aminoundecanoic acid) was incorporated into positions 
2 of anoplin. This amino acid side chain contains 5 
extra carbons compared to Leu, and the hydrophobicity 
of the analogues are thus comparable to that of 
2,3,9,10Hle and 2,10Aoc. They reported a fairly high 
selectivity of 10-20 against E.coli ATCC 8739 upon 
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substitution at position 2. However, they did see a 
decrease in selectivity when inserting their lipophilic 
amino acid in positions 6 and 10, indicating that the site 
of insertion is important. It is important to notice that our 
data set is not sufficient to say where in an AMP the 
residue with increased hydrophobicity should be 
inserted. In our dataset, there are only small 
differences in activity when Cha is inserted in position 2 
or 10, but larger differences were found in other 
studies[14,17]. 
Modulation of hydrophobicity profile 
A small set of the anoplin analogues was designed in 
order to investigate how the activity of anoplin would 
change if the hydrophobicity distribution on the 
hydrophobic face was altered. βNal was inserted in 
position 6, while the side chains of residues 2,3,9, and 
10 were shortened. The analogues with similar or lower 
hydrophobicity than anoplin lost their activity, whereas 
the ones with higher hydrophobicity were able to retain 
the same activity as anoplin. However, their 
hydrophobicities are comparable to that of 2,10Hle, 
which shows a markedly higher antibacterial and 
hemolytic activity. This confirms that the antibacterial 
and hemolytic activity is very dependent on a high 
membrane affinity of the whole molecule and not just a 
single turn of the helix. 
 
Table 4. Activities of anoplin analogues where the hydrophobicity 
profile of the hydrophobic face has been modulated. 
 MIC 
[μM] 
EC50 
[μM] 
Selectivity 
(EC50/MIC) 
Hydrophobicity 
2,10A6(βNal) >200 >500 - 4.37 
2,3,9,10-
Nva6(βNal) 
>200 >500 - 5.83 
Anoplin 100 >500 >5 5.87 
2,10Nva6(βNal) 100 >500 >5 6.49 
3,9Nva6(βNal) 100 >500 >5 6.49 
 
Non-conservative mutations 
The activity data for the three non-conservative 
analogues which were the outset of our work (5K8W, 
5W, and 5F8W) exhibit increasing hemolytic activities 
with increasing hydrophobicity. It would be tempting to 
ascribe this increase in hemolytic activity solely to the 
increase in hydrophobicity. However, 5K8W is still 
relatively selective, while 5W and 5F8W have lost 
selectivity completely. The observation that might 
explain the activity of these analogues is that the 
inserted aromatic residues in 5W and 5F8W can 
interact with the membrane interior whereas the Trp in 
5K8W cannot. Thus, mutations at the membrane-water 
interface (positions 5 and 7 in anoplin) can have a far 
more dramatic consequence on the hemolytic activity. 
This should be kept in mind when designing analogues. 
Table 5. Activities of the non-conservative anoplin analogues. 
 MIC 
[μM] 
EC50 
[μM] 
Selectivity 
(EC50/MIC) 
Hydrophobicity 
Anoplin 100 >500 >5 5.87 
5K8W 12.5 130 10.4 7.88 
5W 37.5 20 0.5 9.13 
5F8W
[a]
 - 2 - 10.66 
[a] Sample could not have its MIC value measured reliably due to 
poor solubility. 
The question remains: If the Trp in position 8 does 
not interact directly with the membrane, why does it 
increase both activity and hemolytic activity of that 
peptide compared to anoplin? The activity of these α-
helical AMPs might be governed by more than just their 
interaction with the lipid part of the membrane, but as of 
now we do not have an answer to what that might be. 
From the set of analogues with substitutions on the 
hydrophobic face of the helix, 2Cha, 10Cha, 2,10Hle, 
2,10Aoc, and 2,10Cha were chosen for structural 
investigation in order to see if an explanation could be 
found for their differences in activity. These analogues 
showed very similar insertion depth profiles as shown 
in Figure 6. The insertion depth of these analogues 
weakly correlates with their hydrophobicity. However, 
these data are not so clear, as the experimental 
uncertainty is in the same order of magnitude as the 
changes in insertion depth observed. The peptide with 
the deepest insertion of this set of peptides is 2,10Cha 
– the most hydrophobic of the investigated analogues. 
When comparing the insertion depth of this analogue 
with those of the peptides with non-conservative 
analogues 5W and 5F8W in Figure 2, a similar insertion 
depth is found for 5W, but a much deeper insertion 
depth is found for 5F8W. This shows that the increased 
hydrophobic face of this analogue places it in a class of 
its own, regarding its insertion depth.  
 
Figure 6. The insertion depth profiles of the analogues which were 
structurally investigated and are not shown in Figures 1 or 6, 
showing the distance of each H
α
 from the micelle center. The 
micelle radius is ≈22.7 Å. These analogues were all made with 
conservative substitutions, and they show that there is only very 
slight changes in insertion depth profiles and that the insertion 
depths are similar. 
After solving the structures of these anoplin 
analogues and performing the restrained refinement, 
an experimental helical wheel projection of the 
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analogues was made. These helical wheels were very 
similar to each other, with no large deviations from the 
theoretically predicted helical wheel, and are thus not 
shown. 
Solubility issues of anoplin analogues 
From the standard MIC determination by the broth 
micro-dilution assay, we found that a few of the 
peptides could not have their MIC value determined 
reliably. To understand what the cause for this was, we 
studied what happens in the first 6 hours of the MIC 
assay by using an oCelloScope. The images generated 
via the oCelloScope showed that not all peptides were 
completely solubilized. Very large aggregates of 
different kinds were observed in samples containing 
2,3,9,10Aoc (filamentous) and 5F8W (crystals) as 
shown in Figure S7. These two peptides did not yield 
reproducible MIC values in either of the used assays. 
Smaller and much more scarce aggregates were 
found in samples containing 2,10Aoc, 5W, 5K8W, 
2,3,9,10Hle, 2,10Cha, and 2,9Cha at high peptide 
concentrations. These peptides yielded reproducible 
MIC values, so it is believed that these smaller 
aggregates are not detrimental to the assay. 
Aggregation seems to occur at hydrophobicities > ≈ 7, 
when using the octanol-water partition coefficient 
derived scale from Fauchère et al [24]. 
How bacteria are killed by anoplin and its 
analogues 
The images from the oCelloScope measurements 
showed a difference in bacterial growth of 5W and 
5F8W compared to the rest of the analogues. In 
general, when the peptide concentration is at or above 
the MIC concentration, bacterial growth is observed for 
approximately 2 hours, after which the bacterial cell 
count drops. The cell growth is measured as surface 
area of cells, and upon inspection of the images of the 
bacterial population it is clear that a large part of the 
detected initial growth is caused by elongation of the 
cells rather than cell division, but there also appears to 
be an increase in the amount of cells. This is illustrated 
in Figure 7. When peptide concentration was below 
MIC, growth occurred with varying growth rates 
depending on concentration and peptide analogue for 
about 2 hours. After this, either a small drop in amount 
of cells, a plateau of constant amount of cells, or 
continued growth at the same rate was observed. This 
is assumed to be a result of how close the peptide 
concentration is to the actual MIC value. After 4 hours, 
growth was observed in all of these samples. 
 
Figure 7. oCellosope images of the growth of E.coli in the presence 
of 2Cha at the MIC. Panel A shows the development of the 
bacterial density (arbitrary unit) in the well over time. Initially, both 
an increase in number and size of cells occurs. After approximately 
2 hours, no more growth occurs, but instead a steady decline in 
intact cells is observed. Panel B: Still image from the beginning of 
the experiments showing very few cells. Panel C: Still image at the 
maximum optical density showing both an increase in number of 
cells and filamentation. Panel D: Still image at the end of the 
experiment showing few normal and elongated cells and a lot of 
particles smaller than E.coli cells, probably cell debris. 
For 5W and 5F8W there was either growth or no 
growth – no plateau or intermediate growth rates were 
observed. These two peptides did not give rise to the 
appearance of elongated bacteria, either. Growth 
curves for E.coli at different peptide concentrations for 
5W and 2,3,9,10Hle are shown in Figure 8.  
These observations have led us to believe that 
anoplin does not work by direct lysing of the bacterial 
cells. This is in accordance with previous studies of 
anoplin, which shows that the primary mode of action is 
not through membrane lysis[19,25]. Instead it somehow 
lowers the growth rate of the bacteria and causes a 
deficiency in the ability of the bacteria to divide, which 
causes some of the cells to grow very long 
(filamentation). This is, however, not the case for 5W 
and 5F8W: They both completely prevent bacterial 
growth from the start and show very high hemolytic 
activities, which have led us to believe that these two 
analogues are indeed cell lysing peptides. This cannot 
be explained by their hydrophobicity alone, as the 
hydrophobicity of 5W is fairly close to that of 
2,3,9,10Aoc. It is more likely a result of the increased 
hydrophobic interaction of these analogues with the 
interior of the membranes. The fact that 5K8W does not 
cause cell lysis while 5W does, supports that residues 
4 and 8 in anoplin cannot interact with the membrane 
interior, as opposed to residues 5 and 7. 
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Figure 8. Growth curves obtained from oCelloScope measurements 
of E.coli in the presence of 2 different peptides. They illustrate the 
difference in method of inhibition which is observed throughout the 
whole data set. 2,3,9,10Hle (upper panel) allows for growth for 
about 2 hours, after which cell death occurs at concentrations 
≥MIC. For concentrations below MIC, the peptide still slows down 
the growth of the bacteria in a concentration dependent manner. 
5W (lower panel), however, inhibits growth immediately upon 
interaction with the cells at concentrations ≥MIC, whereas no 
slowing of growth is seen at concentrations below MIC:  There is 
either growth or no growth. Data are shown from two replicates. 
Applicable structure-activity relationship 
parameters 
In order to explain the activity of all the anoplin 
analogues presented thus far, correlations were sought 
between their activity and the classical structural 
parameters; hydrophobicity, charge, hydrophobic 
moment/amphipathicity, and polar angle, but neither 
were sufficient for explaining the behavior of the set as 
a whole. From the structural studies, we calculated the 
experimentally derived polar angle, hydrophobic angle, 
tilt angle, rotation of Ile6 relative to the micelle center, 
and mean insertion depth, but neither of these proved 
useful as well. 
The only useful parameters we found were those 
used in the description of the results: polarity of the 
polar face and hydrophobicity of the hydrophobic face. 
An increased polarity of the hydrophilic face of the 
peptide is beneficial for antimicrobial activity, and an 
increase in the hydrophobicity of the hydrophobic face 
yields a higher activity against all membranes until a 
threshold is reached. Exceeding this threshold for 
hydrophobicity will primarily increase the hemolytic 
activity of the AMP, and is thus detrimental to its 
selectivity. 
 
Part 3: Designing optimal AMPs 
After obtaining the data presented this far, we decided 
to see how applicable our results were in the design of 
an “optimal” anoplin analogue, and how the principles 
used to improve the activity of anoplin could be 
transferred to another helical AMP. Furthermore, we 
tested whether the anoplin motif could be extended in 
order to obtain longer and more active yet non-
hemolytic AMPs. For these analogues, all the polar 
residues were replaced with Lys. In order to estimate 
how useful our optimized anoplin and citropin 
analogues could be as potential drugs, we decided to 
measure the antibacterial activity of this set of peptides 
against a wider selection of clinically important bacterial 
strains. We selected two Gram-positive and two Gram-
negative bacteria, where one strain of each type is 
classified as a multiresistant strain. The MIC values 
were determined using the broth micro-dilution assay 
and the data are shown in Table 6. 
The optimal anoplin analogues 
Based on the observations of the presented set of 
peptides, 4 substitutions on the hydrophobic face 
appeared appealing: 2,10Hle, 2Cha, 10Cha, and 
2(βNal), as they all had very promising selectivities. Of 
these, we chose to use 2,10Hle due to its similarity of 
the Leu residues originally located in these positions 
and due to the very slight modification that it actually is. 
On the hydrophilic face, Lys or Dab should be in 
position 4 and 8 as these were the most beneficial 
substitutions. 
The results showed that our two optimized anoplin 
analogues 8K-2,10Hle and 4,8Dab-2,10Hle indeed had 
higher activity and improved selectivity against E.coli. 
Furthermore, these compounds showed equally high 
activities against the other bacterial strains which 
classify these analogues as broad spectrum 
compounds. These are the most active and selective 
analogues of anoplin published to date, and the show 
how the careful trimming of polarity of the hydrophilic 
face and of the hydrophobicity of the hydrophobic face 
can be used to optimize a cationic α-helical AMP. 
Optimized citropin analogues 
Based on the insertion depth data on Citropin 
(GLFDVIKKVASVIGGL-NH2) obtained by Franzmann 
et al.[26], three analogues were designed using only the 
classic amino acids which had a higher polarity on the 
hydrophilic face and a stronger hydrophobic face. 
These substitutions gradually replaced Ser, Val, and 
Gly with Lys on the hydrophilic face and Ala and Val 
with Leu on the hydrophobic face. 
As can be seen from the data in table 6, citropin is 
already quite active against Gram-positive bacteria, but 
show poor activity against Gram-negative and exhibits 
a high hemolytic activity. The first two rationally 
32
33 
 
designed analogues of citropin significantly increased 
the activity against the Gram-negative bacteria, thus 
making it into a broad spectrum compound. These two 
analogues also have a moderately increased activity 
against the Gram-positive bacteria. However, the last 
analogue only shows a very modest increase in activity 
against one strain (E.coli). All the designed analogues 
showed increases in hemolytic activity, which was to be 
expected due to an increased hydrophobicity of the 
hydrophobic face. Citropin was already quite hemolytic 
before modification of its sequence, and thus AMPs 
with high selectivity were not obtained. This is despite 
the fact that the hydrophobicity per turn of the helix is 
lower for citropin than for anoplin. 
Extension of the 8K motif 
The extension of the anoplin motif (anoplin+2 turns, 
resulting in GLLKRIKKLLKKIKKLL-NH2) showed an 
increase in activity compared to 8K by a factor of two, 
but it also showed a drastic increase in hemolytic 
activity. In fact, anoplin+2 turns shows less activity than 
4,8Dab-2,10Hle, but 25-fold higher hemolytic activity.  
When increasing the length of the peptide even further 
(anoplin+4 turns, GLLKRIKKLLKKIKKLLKKIKKLL-NH2), 
the compound becomes highly toxic with EC50 < 1μM. 
At the same time, the MIC values could no longer be 
measured reliably, which resembles the data for 5F8W 
and 2,3,9,10Aoc, which showed a strong tendency to 
self-aggregate. 
Despite having the same amphipathicity per turn 
(i.e. the same strength of both the hydrophobic and 
hydrophilic face), the selectivity of the extended anoplin 
analogues is significantly reduced. This is a result of 
making the peptide too hydrophobic. It was observed in 
the first set of peptides, that when traversing a given 
threshold in hydrophobicity, selectivity is very quickly 
destroyed due to drastic increase in hemolysis. The 
longer the peptide becomes, the less hydrophobic each 
turn of the helix should be in order to prevent loss of 
selectivity and ultimately self-aggregation. 
Window of useful hydrophobicity 
For anoplin, it appears that there is a minimum and 
maximum limit to how hydrophobic the hydrophobic 
face of the helix may be, if selectivity should be 
retained. This is illustrated in Figure 9.  
 
Figure 9. Plot of the hydrophobicity of the hydrophobic face of each 
analogue versus their selectivity for E.coli over red blood cells. 
Peptides with a MIC value above 200μM have had their selectivity 
set to 0, and peptides with EC50 value above 500μM have had their 
selectivity calculated as if the EC50 value was 500μM. The plot is 
based on all the anoplin analogues with substitutions on the 
hydrophobic face including the non-conservative substitutions 5W, 
5F8W, and 5K8W. 
When reducing hydrophobicity too much, activity is lost, 
and when increasing hydrophobicity too much, the 
hemolytic activity becomes too high. Staying within this 
window of useful hydrophobicity and modulating the 
polarity of the hydrophilic face allows for analogues 
with maximum selectivity, as illustrated by our 
optimized anoplin analogues. Similar (but not identical) 
limits are probably found for all α-helical AMPs. As 
seen from citropin and the extended anoplin peptides, 
the mean hydrophobicity of the hydrophobic face 
should be reduced upon increasing the length of the 
peptide in order to maintain selectivity. 
Conclusions – the DOs and DON’Ts of 
Rational Design of short α-helical AMPs 
The general activity of an α-helical AMP is modulated 
by the strength of the interaction of its hydrophilic face 
with the lipid head groups and the solvent, and by the 
strength of the interaction of its hydrophobic face with 
the membrane interior. 
Based on the data presented here for anoplin, we 
propose a list of DOs and DON’Ts when trying to 
improve activity of a cationic α-helical AMP. It is 
important to keep in mind that this is only valid for the 
specific group of short cationic α-helical AMPs which 
presumably act by unspecific membrane interaction – 
our conclusions are not applicable to pore forming 
peptides or AMPs with specific targets. 
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Table 6. Activity data on the final set of peptides, which were designed based on the results from the peptides presented in Table 1.  
 EC50 [μM] 
MIC [μM] (selectivity)
[e]
 
S.aureus
[a]
 
MIC [μM] (selectivity)
[e]
 
E.faecium
[b]
 
MIC [μM] (selectivity)
[e]
 
E.coli
[c]
 
MIC [μM] (selectivity)
[e]
 
P.aeruginosa
[d]
 
8K-2,10Hle 500 12.5 (40.0) 12.5 (40.0) 6.3 (79.4) 6.3 (79.4) 
4,8Dab-2,10Hle 250 6.3 (39.7) 6.3 (39.7) 3.1 (80.6) 3.1 (80.6) 
      
citropin
[f]
 40 12.5 (3.2) 6.3 (6.3) 50 (0.8) 200 (0.2) 
10L 11,12K
[g]
 22 12.5 (1.8) 6.3 (3.5) 6.3 (3.5) 50 (0.4) 
9,10L 11,12K
[g]
 9 3.1 (2.9) 1.6 (5.6) 6.3 (1.4) 12.5 (0.7) 
9,10L 11,12,14K
[g]
 6 3.1 (1.9) 1.6 (3.8) 3.1 (1.9) 12.5 (0.5) 
      
anoplin+ 2 turns
[h]
 9 12.5 (0.7) 6.3 (1.4) 12.5 (0.7) 12.5 (0.7) 
Anoplin+ 4 turns
[i]
 <1 - - - - 
[a] Methicillin resistant S.aureus ATCC 33591. [b] Vancomycin resistant E.faecium ATCC 700221. [c] E.coli ATCC 25922. [d] P.aeruginosa ATCC 
27853. [e] The selectivity is defined as EC50/MIC. [f] Citropin sequence: GLFDVIKKVASVIGGL-NH2. [g] Citropin analogues. [h] Anoplin+2 turns 
sequence: GLLKRIKKLLKKIKKLL-NH2. [i] Anoplin+4 turns sequence: GLLKRIKKLLKKIKKLLKKIKKLL-NH2. 
 
- Don’t rely on the helical wheel model when 
designing AMP analogues, especially when 
making non-conservative mutations.  
- Do identify the role of the residues: define for 
each residue whether its role is the interaction 
with the membrane interior, lipid head groups, 
or the bulk solvent. 
- Do increase polarity of residues interacting 
with bulk solvent: An increase in polarity by 
shortening the chain length and increasing 
charge of the hydrophilic face will in general 
increase the activity of the peptide. These 
changes have only little effect on the 
hemolytic activity. For anoplin these are 
residues 4 and 8. The shorter lysine analogue 
Dab is clearly beneficial, but not the even 
shorter analogue Dap. 
- Do change hydrophobicity of the hydrophobic 
face in small steps: An increase in 
hydrophobicity of the hydrophobic face 
increases the activity of the peptide, but when 
exceeding a peptide-length dependent 
threshold value it greatly increases the 
hemolytic activity, thus making the AMP 
unspecific. For anoplin a high degree of 
hydrophobicity is needed in all positions of the 
hydrophobic face, but on longer AMPs the 
hydrophobicity per residue should be lower.  
- Do change hydrophobicity of the hydrophobic 
face only in a few positions: It seems to be 
more beneficial to increase hydrophobicity of 
only a few residues instead of spreading the 
increase across the whole hydrophobic face. 
This might depend on where the increase in 
hydrophobicity is located; our data set is not 
comprehensive enough on this point.  
- Don’t substitute residues interacting with the 
lipid head groups with hydrophobic residues: 
Higher activity of a peptide can be achieved 
by inserting hydrophobic residues instead of 
hydrophilic ones. However, when this is done 
in positions which enables the hydrophobic 
side chain to interact with the membrane 
interior (by bending), the peptide will lose 
selectivity due to large increases in hemolytic 
activity. 
Experimental Section 
Materials 
All standard Fmoc protected amino acids were purchased 
from Iris Biotech, all non-classic amino acids from 
Novabiochem, α-cyano-4-hydroxycinnamic acid (CCA) 
from Bruker Daltonics, DPC-d38 (98% D) from Cambridge 
Isotope Laboratories, and the remaining chemicals were 
purchased from Sigma-Aldrich unless stated otherwise. 
Peptide Synthesis 
All peptides shown in Tables 1-5 were synthesized by 
Fmoc solid state peptide synthesis
[27]
 using TentaGel S 
(200 mg RAM resin with 0.24 mmol/g) as solid support. 
Coupling was performed twice for each amino acid using 
Fmoc protected amino acid (3 equiv.), N,N’-
Diisopropylcarbodiimide (DIC) (3 equiv.), and 1-hydroxy-7-
aza-benzotriazole (HOAt) (3 equiv.) dissolved in N-methyl-
2-pyrrolidone (NMP) for 1.5 hours. Deprotection was done 
using 20 % piperidine in NMP first for 3 min and then for 7 
min. Between each coupling and deprotection step, the 
resin was washed 7 times with NMP. Cleavage of peptides 
from resin was performed in 95% trifluoroacetic acid 
(TFA)/5% triisopropyl silane (TIS) for 2 hours. The resin 
was then washed with 100% TFA. Solutions from cleavage 
and washing were collected and pooled. The peptides 
were subsequently precipitated and washed twice in 
diethyl ether, before lyophilization. 
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All peptides shown in Table 6 were purchased from 
GenScript (USA inc, www.genscript.com), purified to 
>98%. 
HPLC Purification 
The lyophilized peptides were dissolved in 1mL of 50% 
acetonitrile in water, to which two drops of 99.8% acetic 
acid were added. Purification was done using a Grace 
C18-reverse-phase column (10-15 μm dp, 300 Å pore size) 
on a Waters system and Empower Pro software.  
Mass Spectrometry 
Masses of the purified peptides were measured using 
matrix-assisted laser desorption ionization-Time of flight 
mass spectrometry (MALDI-TOF MS) using a Bruker 
Microflex A099-01 MALDI. The samples were prepared 
using CCA as matrix. 
NMR quantification 
The purified peptide samples were lyophilized and 
dissolved in a freshly made solution (550μl) of TFE (5 mM) 
in D2O and transferred to NMR tube. The samples were 
measured using the standard 1D 
1
H Bruker pulse 
sequence with a relaxation delay between scans of 30s. 
Quantification was done by integrating resonances of 
lysine H
ε
 and Arg H
δ
 (CH2 group) using the CH2 group of 
TFE as internal standard. 
Broth micro-dilution assay: 
The MIC of the peptides were either tested on E.coli ATCC 
25922 alone or on the four strains listed in Table 2 by the 
broth micro-dilution method 
[22]
 in 96-well polypropylene 
micro titer plates. The strain suspensions used in the test 
were diluted to reach a concentration at 5x10
5
 CFU/mL in 
Mueller-Hinton II bouillon. The peptides were diluted in a 
series of twofold dilutions ranging from 256 to 0.25 μg/mL 
in Mueller-Hinton II bouillon. The bacterial strains were 
incubated for 18 hours after which the MIC values were 
read as the lowest concentration of peptide where there 
was no visible growth. The antibiotic gentamycin was used 
as control.  
oCelloScope 
Experiments were performed on the Gram-negative 
facultative aerobe bacterium, E.coli ATCC 25922. An 
overnight culture (0.1 mL) was inoculated in 8 mL of 
Müller-Hinton broth (Merck, VWR, Herlev, Denmark) for 2 
h (37°C) to reach the exponential phase. The cell 
suspensions were standardized by adjusting the 
concentration of inoculates to 2.3x10
7
 cells/mL, determined 
by measurements of the optical density at 600 nm (UV-
3100 PC spectrophotometer; VWR, Herlev, Denmark), and 
subsequently diluting to a final bacterial cell suspension of 
5x10
5
 cells/mL. Beads were added to bacterial cell 
suspensions in order to focus the microscope (2×10
4
 6-μm 
beads/mL, microsphere standard, B-7277; Invitrogen, 
Naerum, Denmark) and loaded onto an F-base microtiter 
plate (50 μL/well) (Sigma-Aldrich, Brøndby, Denmark) 
either untreated (control samples) or treated with antibiotic 
peptides of interest. 
Antibiotic susceptibility tests were performed using the 
oCelloScope detection system (Unisensor A/S, Allerød, 
Denmark). Each well was scanned repeatedly every 10 
min. Time-lapse experiments, digital analysis, and image 
processing were conducted by use of the pixel histogram 
summation algorithm as previous described 
[21]
. The 
oCelloScope was placed within an Innova 44 incubator 
(New Brunswick Scientific) in order to keep the 
temperature constant at 37ºC. 
An initial screening was performed with peptides in a 
series of twofold dilutions ranging from 256 to 0.25 μg/mL. 
Then, two series were performed with peptides in 
concentrations of 50%, 75%, 100%, 150%, and 200% of 
the MIC value observed in the initial screening. 
Hemolytic activity assays 
Human erythrocytes (0 rhesus positive) were washed three 
times with phosphate buffered saline (PBS) (0.15 M), 
followed by centrifugation for 2x8 minutes at 3000 rpm and 
1x8 minutes at 4000 rpm. After washing, the erythrocytes 
were diluted to 0.5% v/v in 0.15 M PBS. 0.75μL of the 
erythrocyte solution was added to a 96-well polypropylene 
plate with V-shaped bottoms together with peptide solution 
(0.75 μL). The peptides were diluted in a series of twofold 
dilutions ranging from 500 to 0.98 μg/mL. The plate was 
then incubated at 37°C for 1 hour. After incubation, the 
plate was centrifuged for 10 min at 4000 rpm. The 
supernatant was transferred to a 96-well polystyrene 
microtiter plate and the absorbance was read with an 
ELISA reader at 414 nm. Triton-X-100 (0.2%) was used as 
positive control (100% hemolysis)  
NMR Spectroscopy 
For structural analysis, each peptide was dissolved to 3 
mM, 5% D2O, NaN3 (2 mM) and  DPC-d38 (98% D) (150 
mM) in phosphate buffer (10 mM), pH 6.5. 
All spectra were recorded on a Bruker DRX 600 
spectrometer with a 5mm TXI(H/C/N) or a 5mm TCI 
(H/C/N) probe, and on a BRUKER AV 900 spectrometer 
with a 5mm TCI (H/C/N) probe. For all peptides, NMR data 
were recorded at 37ºC. However, in some cases, 
additional NMR data measured at 20 ºC were used for 
resolving overlapping spin systems. TopSpin v. 1.3 was 
used for recording and TopSpin v. 2.1 was used for 
processing NMR data. The following spectra were 
recorded: 
1
H-
1
H-TOCSY with 75 ms mixing time, 
1
H-
1
H-
NOESY with 60 ms mixing time, 
1
H-
13
C-HSQC at natural 
abundance, and occasionally 
1
H-
1
H-COSY. Watergate was 
used for water suppression in homonuclear 2D-spectra. 
The individual spin systems were assigned in the 
1
H-
1
H-
TOCSY spectra using CARA v. 1.8.4 with the aid of the 
1
H-
13
C-HSQC, 
1
H-
1
H-COSY, and 
1
H-
1
H-NOESY spectra. 
Subsequently, integration of NOE cross peaks were 
performed in the NEASY subroutine of CARA v. 1.5.5.
[28]
 
The C
α
 and C
β
 chemical shifts were obtained from the 
1
H-
13
C-HSQC spectra and used to calculate backbone torsion 
angle restrains using the program TALOS+.
[29]
 
NMR assignments have been submitted to the 
BioMagResBank (anoplin: 11551, 5W: 11552, 5K8W: 
11553, 5F8W: 11554). 
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PRE constraints 
PRE constraints were derived as described by Franzmann 
et al.
[18]
 Eight inversion recovery NOESY spectra with 
recovery delay times of 1, 50, 150, 400, 700, 1200, 2600, 
and 4000 ms were recorded at 600 MHz in a pseudo-3D 
manner for each of the four Gd(DTPA-BMA) titration 
points: 0, 2, 5, 10 mM. All the reliable peaks with H
α
 in the 
indirect dimension were integrated in all spectra in the 
NEASY subroutine of CARA v. 1.5.5. R1 relaxation rates 
were determined, and by a linear fit of the relaxation rates 
for the 4 titration points the PRE values were determined. 
The PRE values were then averaged for each H
α
 and 
converted to distance restraints to the micelle center. 
These restraints were used as upper and lower distance 
restraints with values of plus and minus 1Å, respectively. 
The PRE distance restraints were weighted with 10% 
compared to the NOE distance restrains, in order to 
prevent distortion of the peptide structure. 
On the basis of the NOE-derived distance constraints, 
angle restraints, and PRE-derived distance restraints, 80 
structures of each peptide were calculated using CYANA v. 
2.1,
[30]
 after which, the 20 structures with the lowest target 
function value were chosen for restrained refinement. 
Restrained refinement 
The 20 output structures from CYANA were energy 
minimized using YASARA.
[20]
 The peptide structures were 
loaded one at a time into a simulation cell together with a 
DPC micelle obtained from the homepage of Professor 
Peter Tieleman at the University of Calgary 
(http://moose.bio.ucalgary.ca).
[31]
 For each peptide, 10 
repetitions of the refinement were performed, and for each 
repetition, the DPC micelle was oriented randomly before 
simulation start in order to insert the peptide at different 
locations. Then the peptide is pulled into the micelle by 
adding the PRE distance restraints. Subsequently, the 
molecular dynamics simulation is turned on in order to 
minimize the van der Waals repulsion between the atoms 
of the soup. This energy minimization is initially done in 
vacuo using the NOVA force field. After this initial 
refinement, the simulation cell is filled with water 
molecules. The,n another round of restrained molecular 
dynamics simulation is performed using the YASARA force 
field, and final structure statistics are calculated. 
Finally, out of the 10 refinement repetitions for each input 
peptide structure, the structure with the lowest constraint 
violation energy is selected for the final ensemble. 
Geometrical analysis 
The orientation of the side chains in each of the final 
structures were calculated in two steps: first, the helical 
axis was calculated by the GroupLine command in 
YASARA, returning a regression line optimally fitting the 
backbone atoms (N+C+C) of residues 2-10 (the ones that 
were folded into helix). From this line, the direction towards 
the geometric mean of each side chain or H
α
 relative to the 
direction towards the micelle center was calculated. 
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There are lots of examples on how the activity of -helical antimicrobial peptides has been enhanced. 
However, general guidelines have not yet been reported. Here, we investigate the effect of mutations on 
the structure and membrane insertion of peptides, present structure-based guidelines to enhance activity 
and selectivity of small -helical antimicrobial peptides, and put them to the test. 
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Supplementary Material 
           
           
Figure S1: Graphical overview of the NOEs used for the structure calculations of each peptide.  
anoplin 5W 
5F8W 5K8W 
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 Anoplin R5W R5F_T8W R5K_T8W 
Number of distance constraints  
   Intra-residue 
   Sequential (i-j=1) 
   Medium-range (1<i-j<5) 
   To micelle center 
 
44 
22 
28 
15 
 
49 
33 
59 
14 
 
52 
28 
27 
15 
 
64 
28 
15 
12 
TALOS+ derived dihedral angle constraints  
   φ Angles 
   Ψ Angles 
 
6 
6 
 
8 
8 
 
7 
7 
 
7 
7 
RMSD for residue 2-10 
   Average backbone (N + C
α
 + C)  
   Average heavy atoms 
 
0.19±0.06 
1.07±0.23 
 
0.16±0.04 
0.79±0.17 
 
0.24±0.10 
1.18±0.21 
 
0.24±0.10 
1.04±0.27 
Constraint violations 
   No of NOE constraint violations > 0.1Å 
   Maximum NOE violation 
   No of Dihedral angle constraint violations > 5° 
   Maximum PRE constraint violation 
 
0 
0.1 
0 
0.31 
 
0 
0.099 
1 
0.15 
 
0 
0.1 
4 
0.22 
 
0 
0.1 
0 
0.29 
Ramachandran plot statistics 
   Residues in favored regions 
   Residues in additional allowed regions 
   Residues in generally allowed regions 
   Residues in disallowed regions 
 
96.9% 
1.3% 
0% 
1.9% 
 
100% 
0% 
0% 
0% 
 
97.5% 
0.6% 
0.6% 
1.3% 
 
99.4% 
0.6% 
0% 
0% 
Average energy results (kJ/mol) 
   Total energy 
   Electrostatic solv. Energy 
   Van der Waals solv. energy 
 
-36718±926 
-23044±1211 
-4077±217 
 
-33967±1261 
-22507±980 
-4107±185 
 
-35013±1132 
-22728±1223 
-4014±247 
 
-34664±2543 
-22414±1022 
-4041±143 
Table S2: A list of the amount and types of constraints used for calculation of the peptide structures 
followed by statistics for the ensembles of structures after restrained refinement in YASARA. The PRE 
derived distance constraints to the micelle center are mainly from H, but in cases where the H
N
 shows no 
water exchange peak, distance constraints from H
N
 to the micelle center were also included. The PRE 
constraint violations are of higher magnitude than the NOE constraint violations. This is a consequence of 
the weighting of the PRE constraints relative to NOE constraints. The maximum PRE constraint violation 
was 0.31 Å and is thus quite small in relation to the length of the constraints, where the minimum 
distance was approximately 14 Å. 
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anoplin R5W
residue insertion depth No. of peaks RMSD lower limit upper limit insertion depth No. of peaks RMSD lower limit upper limit
2 19.31 2 0.013 19.03 19.56 17.92 5 0.008 17.64 18.17
3 17.32 7 0.006 17.05 17.57 16.53 6 0.008 16.13 16.89
4 21.61 3 0.007 21.55 21.66 21.52 3 0.013 21.40 21.63
5 21.34 5 0.055 20.77 21.80 20.29 6 0.044 19.56 20.85
6 16.04 4 0.009 15.48 16.52 16.13 3 0.009 15.61 16.58
7 19.01 7 0.018 18.56 19.40 18.89 2 0.000 18.88 18.89
8 23.16 3 0.045 22.98 23.33 22.45 1 - - -
9 20.23 4 0.014 20.02 20.42 19.75 5 0.033 19.10 20.28
10 18.99 3 0.011 18.72 19.25 18.52 3 0.002 18.47 18.56
R5F_T8W R5K_T8W
residue insertion depth No. of peaks RMSD lower limit upper limit insertion depth No. of peaks RMSD lower limit upper limit
2 16.87 5 0.007 16.54 17.17 18.5 1 - - -
3 16.82 7 0.004 16.63 17.00 17.03 4 0.002 16.94 17.12
4 21.05 4 0.009 20.95 21.14 21.46 4 0.027 21.21 21.68
5 18.71 5 0.005 18.58 18.83 22.22 4 0.029 22.03 22.39
6 14.68 6 0.007 14.01 15.25 16.26 3 0.002 16.14 16.39
7 18.92 5 0.009 18.70 19.12 18.88 5 0.019 18.38 19.31
8 21.38 1 - - - 22.91 4 0.066 22.60 23.18
9 17.11 4 0.003 17.00 17.22 20.24 3 0.032 19.73 20.66
10 18.08 3 0.002 18.00 18.15 18.79 3 0.012 18.49 19.07
 
Table S3: Raw data obtained from the paramagnetic relaxation enhancement experiments for 
anoplin and the three analogs R5W, R5F_T8W, and R5K_T8W. The quantity of paramagnetic 
relaxation enhancement is defined as the slope of the linear fit to the relaxation rates obtained 
from the titration steps. This slope is calculated for each useful Hα NOESY cross peak for each 
residue. The insertion depth is then calculated based on the average slope for each residue. The 
RMSD value is calculated for the slopes, and when subtracting and adding this value from the 
mean slope, the lower and upper limits of insertion depth are calculated.  
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Figure S4: Example for 1H-NMR spectra used to quantify peptides: region of the 1D NMR 
spectrum of 10Cha in the presence of 5mM TFE. The peak integrals have been normalized to of 
the CH2 group of TFE (integral=1.00). The triplet at 3.13 ppm (integral 1.05) is the signal of Arg5 
Hδ and the multiplet at 2.84 ppm (integral 2.13) is the signal of Hδ of both  Lys4 and Lys7.  
  
42
43 
 
Table S5. Overview of the activities of the anoplin analogs
[a]
. 
Peptide Sequence MIC 
[μM]
[b]
 
EC50 
[μM]
[c]
 
Selectivity index
[d]
 Hydrophobicity
[e]
 
 
Substitutions on the hydrophilic face
[f]
 
4T GLLTRIKTLL-NH2 200 >500 >2.5 7.12 
4Hser GLLHserRIKTLL-NH2 150 >500 >3.3 ~7.12 
4S GLLSRIKTLL-NH2 100 >500 >5 6.82 
Anoplin GLLKRIKTLL-NH2 100 >500 >5 5.87 
4Orn GLLOrnRIKTLL-NH2 100 >500 >5 5.75 
8S GLLKRIKSLL-NH2 100 >500 >5 5.57 
4Dab GLLDabRIKTLL-NH2 75 >500 >6.7 5.52 
4Dap GLLDapRIKTLL-NH2 100 >500 >5 5.26 
5K8K GLLKKIKKLL-NH2 25 >500 >20 4.64 
8K GLLKRIKKLL-NH2 25 >500 >20 4.62 
4,8Dab GLLDabRIKDabLL-NH2 12.5 >500 >40 3.92 
      
Substitutions on the hydrophobic face 
2,3,9,10(O-Me-Ser) G(O-Me-Ser)(O-Me-Ser)KRIKT(O-Me-Ser)(O-Me-Ser)-NH2 >200 >500 - ~0.11 
2,10(O-Me-Ser) G(O-Me-Ser)LKRIKTL(O-Me-Ser)-NH2 >200 >500 - ~2.29 
2,3,9,10V GVVKRIKTVV-NH2 >200 >500 - 3.95 
2,3,9,10M GMMKRIKTMM-NH2 >200 >500 - 3.99 
2(O-Me-Ser) G(O-Me-Ser)LKRIKTLL-NH2 >200 >500 - ~4.43 
2,3,9,10Nva GNvaNvaKRIKTNvaNva-NH2 >200 >500 - 4.55 
2,10V GVLKRIKTLV-NH2 >200 >500 - 4.91 
3,9M GLMKRIKTML-NH2 >200 >500 - 4.93 
2,10M GMLKRIKTLM-NH2 >200 500 <2.5 4.93 
2,10Nva GNvaLKRIKTLNva-NH2 >200 >500 - 5.21 
2M GMLKRIKTLL-NH2 200 400 2 5.4 
Anoplin GLLKRIKTLL-NH2 100 >500 >5 5.87 
2,10Nle GNleLKRIKTLNle-NH2 100 >500 >5 5.87 
2,3,9,10Nle GNleNleKRIKTNleNle-NH2 100 >500 >5 5.87 
2,10Epa GEpaLKRIKTLEpa-NH2 50 >500 >10 ~6.57 
2,10Hle GHleLKRIKTLHle-NH2 12.5 380 30.4 ~6.57 
2Cha GChaLKRIKTLL-NH2 25 500 20 6.89 
10Cha GLLKRIKTLCha-NH2 12.5 350 28 6.89 
2(βNal) GβNalKRIKTLL-NH2 6.25 300 48 7.25 
2,3,9,10Hle GHleHleKRIKTHleHle-NH2 12.5 125 10 ~7.27 
2,10Aoc GAocLKRIKTLAoc-NH2 6.25 71 11.4 ~7.27 
2,9Cha GChaLKRIKTChaL-NH2 12.5 120 9.6 7.91 
2,10Cha GChaLKRIKTLCha-NH2 6.25 100 16 7.91 
2,3,9,10Aoc
[g]
 GAocAocKRIKTAocAoc-NH2 - 20 - ~8.67 
      
Modulation of hydrophobicity profile 
2,10A6(βNal) GALKRβNalKTLA-NH2 >200 >500 - 4.37 
2,3,9,10Nva6(βNal) GNvaNvaKRβNalKTNvaNva-NH2 >200 >500 - 5.83 
Anoplin GLLKRIKTLL-NH2 100 >500 >5 5.87 
2,10Nva6(βNal) GNvaLKRβNalKTLNva-NH2 100 >500 >5 6.49 
3,9Nva6(βNal) GLNvaKRβNalKTNvaL-NH2 100 >500 >5 6.49 
      
Non-conservative substitutions 
Anoplin GLLKRIKTLL-NH2 100 >500 >5 5.87 
5K8W GLLKKIKWLL-NH2 12.5 130 10.4 7.88 
5W GLLKFIKTLL-NH2 37.5 20 0.5 9.13 
5F8W
[g]
 GLLKFIKWLL-NH2 - 2 - 10.66 
[a] The full names of the non-classic amino acids are given in the abbreviation list, and their structures are shown in Figure S4. [b] Measured against E.coli 
ATCC 25922. [c] Hemolytic activity measured against human erythrocytes (0 rhesus positive). [d] The selectivity index is defined as EC50/MIC. [e] The 
residual hydrophobicities are obtained from the work of Fauchère
[24]
. This scale was selected because it contained experimental data on some of the non-
classic amino acids. The hydrophobicities with a “~” in front are estimated by extrapolation of the loss or gain in hydrophobicity upon removing or adding a 
CH2 group to functionally identical side chains. [f] For this set of peptides, a reduction in hydrophobicity equals an increase in polarity of the polar face. [g] 
Sample could not have their MIC value measured reliably due to poor solubility.  
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Figure S6: structures of the non-classic amino acids used in this paper. HSer=homoserine, Orn=ornithine, 
Dab=2,4-diaminobutanoic acid, Dap=2,3-diaminopropanoic acid, O-Me-Ser=O-methyl-serine, 
Nva=norvaline, Nle=norleucine, Epa=2-amino,3-ethylpentanoic acid, Hle=homoleucine, Aoc=2-
aminooctanoic acid, Cha=3-cyclohexylalanine, Nal=3(2-naphtyl)alanine 
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Figure S7: Microscopy images of the sample solutions obtained from the oCelloScope experiments.  A: 
Obtained from 100μM of 5F8W dissolved in Mueller Hinton II bullion. B: Obtained from 100μM of 
2,3,9,10Aoc dissolved in Mueller Hinton II bullion. 
A B 
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Abstract 
The inclusion of peptoid monomers into antimicrobial peptides (AMPs) increases their proteolytic resistance, but 
introduces conformational flexibility (reduced hydrogen bonding ability and cis/trans isomerism). We here use NMR 
spectroscopy to answer how the insertion of a peptoid monomer influences the structure of a regular α-helical AMP 
upon interaction with a DPC micelle. Insertion of [(2-methylpropyl)amino]acetic acid in maculatin-G15 shows that the 
structural change and conformational flexibility depends on the site of insertion. This is governed by the micelle 
interaction of the amphipathic helices flanking the peptoid monomer and the side chain properties of the peptoid and 
its preceding residue.  
 
Keywords 
Antimicrobial peptides, peptoids, NMR, maculatin, paramagnetic relaxation enhancement 
 
Abbreviation 
AMP: antimicrobial peptide, CCA: α-cyano-4-hydroxycinnamic acid, COSY: correlation spectroscopy, DIPCDI: 
Diisopropylcarbodiimide, DPC: dodecyl phosphocholine, Fmoc: fluorenylmethyloxycarbonyl chloride, Gd(DTPA-BMA): 
Gadolinium diethylenetriaminepentaacetic acid bismethylamide, HPLC: high pressure liquid chromatography, HSQC: 
heteronuclear single quantum coherence,  Nleu: [(2-methylpropyl)amino]acetic acid, NOE: nuclear Overhauser effect, 
NOESY: nuclear Overhauser effect spectroscopy, PRE: paramagnetic relaxation enhancement, RMSD: root mean 
square deviation, SDS: sodium dodecyl sulfate, TFA: trifluoroacetic acid, TFE: triflouroethanol, TIS: triisopropyl silane, 
TOCSY: total correlation spectroscopy. 
 
Highlights 
 A high-resolution structure of a peptoid-peptide hybrid (“peptomer”) is presented 
 The peptoid residue breaks the helix and displays cis/trans isomerism 
 Maculatin-Nleu11 displays only the trans isomer 
 Maculatin-Nleu13 displays almost equimolar amounts of cis and trans conformers 
 Peptide amphipathicity and peptoid hydrophobicity govern the cis/trans isomerism 
Introduction 
Antimicrobial peptides (AMPs) hold great potential as 
future antibiotics, as they show high antimicrobial 
activity against even multiresistant bacteria. However, 
AMPs are prone to proteolytic degradation and thus 
have short life times in the body. In order to increase 
proteolytic stability of AMPs, several peptidomimetics 
are researched. These include D-amino acids, 
peptoids, β-peptides, and hybrids hereof.
1–6
 
 
Single peptoid (N-substituted glycine
7
) residues in a 
peptide chain are conformationally flexible, as 
backbone hydrogen bonding is impossible due to the 
absence of H
N
 atoms, which are a major participant in 
stabilizing secondary structures. Furthermore, the cis 
and trans conformations can be equally favorable, 
causing the presence of both conformations.
8
 
Hybrids of peptides and peptoids are called 
”peptomers”
9
 and examples of these have been found 
in nature, e.g. cyclosporine. (The term “peptomer” is, 
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however, also used for polymers of peptides without 
any peptoid residues.
10
) Artificial peptomers have 
been constructed as mimics of bacterial quorum 
sensing signals
11
, synthetic inhibitors of a kinase
12
, or 
as novel pharmaceuticals
13
. Lee et al introduced 
peptoid residues into folded ribonuclease A and 
demonstrated that the resulting peptomer still 
retained some activity.
14
 
 
Peptoid residues were also successfully incorporated 
into AMPs: Incorporation of two alanine peptoid 
residues into the hydrophobic face of an α-helical 
AMP significantly reduced its hemolytic activity but 
not its antibacterial activity.
15
 Substituting some of 
the leucine resiudes in the zipper motif of melittin 
with different peptoid residues resulted in helix 
disruption, but the antibacterial activity was still 
intact (while hemolysis was significantly reduced).
16
 
Also hybrids with alternating peptide/peptoid building 
blocks were shown to have antimicrobial    
activity.
3,17–19
 
 
In this work, we investigate the effect of a single 
peptoid substitution on the structure of an α-helical 
AMP bound to a micelle. We have chosen maculatin 
as model AMP. Wild type maculatin 1.1, is a cationic 
21 amino acid AMP (GLFGVLAKVAAHVVPAIAEHF-NH2) 
extracted from the Australian frog Litoria 
genimaculata.
20
 Maculatin exhibits antimicrobial 
activity against various microbial strains. It is 
unstructured in water, but in the presence of 50% TFE 
or DPC micelles it folds into an α-helix with a slight 
kink at Pro 15.
21
 Maculatin-G15 (P15G mutation)
22
  
was found to fold into a complete α-helix in the 
presence of DPC micelles (Figure 1A). We use the 
continuous α-helix in maculatin-G15 as the scaffold 
for studying both the local and global structural 
consequences of inserting a peptoid monomer into a 
regular α-helical AMP. As model peptoid residue, we 
chose Nleu, [(2-methylpropyl)amino]acetic acid 
(Figure S1), as its side chain is identical to that of 
leucine, a very frequent amino acid in AMPs. 
 
Materials and Methods 
Materials 
All standard Fmoc protected amino acids, 99.5% 
Isobutylamine, 99% bromoacetic acid, trifluoroacetic 
acid (TFA), and triisopropyl silane (TIS), were 
purchased from Fluka. Piperidine and N,N’-Diiso-
propylcarbodiimide (DIPCDI) from Iris Biotech. α-
cyano-4-hydroxycinnamic acid (CCA) from Bruker 
Daltonics. DPC and SDS from Avanti Polar Lipids and 
DPC-d38 (98% D) and SDS-d25 (98% D) from Cambridge 
Isotope Laboratories, and the remaining chemicals 
were purchased from Sigma-Aldrich. 
 
Peptide Synthesis 
Peptomers were synthesized using Fmoc solid phase 
peptide synthesis and the submonomer approach
23,24
, 
purified by HPLC, and verified by mass spectroscopy 
as described before.
3
 
 
Calculation of Expected Short Distances 
Starting from the structures of cis and trans-
maculatin-Nleu11, respectively, distances between 
atoms of interest were calculated while systematically 
varying one or two dihedral angles. Dihedral angles 
were defined as following with Nleu as residue i: 
φi: Ci-1-Ni-C
α
i-C’i, ψi: Ni-C
α
i-C’i-Ni+1. In the case of Nleu, 
χ1 was defined as Ci-1-Ni-C
β
i-C
γ
i. 
 
NMR Spectroscopy 
Each peptide was dissolved to 3 mM in 10 mM 
phosphate buffer, pH 6.5, containing 5% D2O, 2 mM 
NaN3 and, 150 mM DPC-d38 or SDS-d25. 
Spectra were recorded on Bruker DRX600 
spectrometers at 37ºC. Additional spectra measured 
at 20 ºC were used for resolving overlapping spin 
systems. TopSpin v. 1.3 and 2.1 were used for 
recording processing NMR data. The following spectra 
were recorded: 
1
H-
1
H-TOCSY (75 ms mixing time), 
1
H-
1
H-NOESY (60 ms mixing time), 
1
H-
1
H-COSY and 
1
H-
13
C-HSQC (natural abundance). Excitation sculpting
25
 
was used for water suppression in homonuclear 2D-
spectra. 
The individual spin systems were assigned in the 
1
H-
1
H-TOCSY spectra using CARA v. 1.8.4 with the aid of 
the 
1
H-
13
C-HSQC, 
1
H-
1
H-COSY, and 
1
H-
1
H-NOESY 
spectra. Subsequently, integration of NOE cross peaks 
were performed in the NEASY subroutine of CARA v. 
1.5.5 
26
. C
α
 and C
β
 chemical shifts were obtained from 
the 
1
H-
13
C-HSQC spectra and used to calculate 
backbone torsion angle restrains using the program 
TALOS+.
27
 The peptoid residue itself and the residues 
preceding and succeeding the peptoid residue, were 
excluded from TALOS+ analysis. 
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Figure 2: Plots of sequential and medium-range NOEs vs. sequence visualizing secondary structure information contained in the NOESY spectra from 
different maculatin derivatives: A: Maculatin-Gly15 in DPC micelles, B: M-Nleu-11 in DPC micelles, C: trans-M-Nleu-13 in SDS micelles, D: cis-M-Nleu-
13 in SDS micelles. “X” denotes the peptoid residue Nleu. In case of chemical shift degeneracy between atoms of M-Nleu-13 in the cis and trans 
conformers, the cross peaks were assumed to be present in both conformations. 
 
 
PRE Constraints 
PRE constraints were derived as described by 
Franzmann et al.
28
 Eight inversion recovery NOESY 
spectra with recovery delay times of 1, 50, 150, 400, 
700, 1200, 2600, and 4000 ms were recorded in a 
pseudo-3D manner for each of the four Gd(DTPA-
BMA) titration points: 0, 2, 5, 10 mM. All peaks with 
H
α
 in the indirect dimension were integrated in all 
spectra. R1 relaxation rates were determined, and by 
a linear fit of the relaxation rates for the 4 titration 
points the PRE values were determined. PRE values 
for each H
α
 were then converted to distance 
restraints to the micelle center as described
28
: If there 
was more than one PRE value for a given H
α
, we used 
the average value of obtained distances. For H
α
 
yielding three or more PREs, we also calculated the 
standard deviation of the distances. Standard 
deviations for the PRE derived distances were 
between 0.1 and 1.0 Å. Thus, all PRE derived distances 
were used as upper and lower distance restraints with 
values of average distance ±1 Å, respectively, also for 
atoms yielding less than three PREs, not permitting 
the calculation of standard deviations. PRE-derived 
distance restraints were weighted with 10% 
compared to the NOE-derived distance restraints.
28
 
 
Structure Calculation 
A pseudoatom representing the micelle center was 
attached to the C-terminal end of the peptide by a 
≈70Å flexible linker consisting of pseudoatoms 
(CYANA residues -LL-LL2-LL2-(LL5)11-(LL2)4-LL-). On the 
basis of the NOE-derived distance constraints, angle 
restraints and PRE-derived distance restraints, 80 
structures of each peptide were calculated using 
CYANA v. 2.1
29
. The 20 structures with the lowest 
target function value were included in the final 
structure ensemble. For overlapping NOE peaks 
between the cis and trans conformer, 90% of the total 
peak intensity was used. The resulting integral values 
were then split according to the ratio of 1.3 between 
the trans and cis conformer. This ratio was found as 
an average based on the peak intensities of 
completely resolved peaks in the TOCSY spectra. 
 
Results 
It is advantageous for the structure calculation of a 
peptomer that the conformation of the peptoid 
monomer (cis or trans) is determined to start with. 
Cis and trans conformations each show characteristic 
short distances: the distance between H
N
(i-1) and H
α
i 
(with i denoting the peptoid residue) is in the trans 
conformation bigger than 3.6 Å, while this distance in 
the cis conformation can be <2.5 Å, depending on ψ(i-
1). Independent of φ(i-1) and ψ(i-1), this distance will 
always be shorter in the cis than in the trans 
conformation. This behavior is opposite for the 
distance between H
N
(i-1) and H
β
i. Likewise, the 
distances between H
α
(i-1) and H
α2,3
i are shorter in the 
cis conformation, while the distances H
α
 (i-1) and H
β2,3
i 
are shorter in the trans conformation (Figure S2). 
The sequences of the two maculatin-G15 analogs 
investigated in this study are: 
M-Nleu11        GLFGVLAKVA-Nleu-HVVGAIAEHF-NH2  
M-Nleu13        GLFGVLAKVAAH-Nleu-VGAIAEHF-NH2  
M-Nleu11 showed only one conformer when bound 
to SDS or DPC micelles and was found to have a trans 
conformation of the Nleu residue based on the NOESY 
cross peaks from H
α
 Ala10 to H
β
 Nleu11 (Figure 2). 
The insertion of the molecule into the DPC micelle 
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was determined by paramagnetic relaxation 
enhancement (PRE) experiments. These data are 
shown in Figure 3 and were used as restraints for the 
structure calculations. 
 
Figure 3: Region of a NOESY spectrum of M-Nleu11 in DPC micelles 
containing the NOEs for distinguishing cis and trans peptoid 
conformation. It shows the absence of H
α
(i-1) – H
α
(i) NOEs and the 
presence of the H
α
(i-1) – H
β
(i) NOEs (with i denoting the peptoid 
residue). The NOESY section also shows weak cross peaks between 
H
α2
 and H
β2/3
 of Nleu 11. 
 
M-Nleu13 exhibited an almost equal distribution 
between cis and trans isomers of Nleu, and both 
structures were solved bound to SDS micelles. Useful 
PRE data could not be obtained for this analog, 
because of H
α
 chemical shift degeneracy between the 
two conformations. 
 
NMR assignments and structure ensembles of M-
Nleu11 in DPC micelles and M-Nleu13 (cis and trans) 
in SDS micelles have been submitted to the PDB and 
BMRB databases. The structural statistics and 
accession codes are given in Table 1. 
Analysis of NOE patterns show that all three 
structures showed a well-defined α-helix in both ends 
of the molecule, with a flexible region around the 
Nleu residue (Figure 1). 
It was possible to obtain insertion depth data for M-
Nleu11 in DPC, which determined the orientation of 
the two terminal α-helices relative to each other. The 
structure ensemble resulting from the use of PRE 
derived restraints is rigid around the peptoid residue, 
yielding lower average backbone RMSD for M-Nleu11 
than for M-Nleu13. The final structure ensemble of 
M-Nleu11 is shown in Figure 4C. Its hydrophobic 
residues are oriented towards the micelle center, the 
polar and Gly residues are oriented towards the lipid 
head groups and solvent surrounding the micelle 
(except for His20), and the Ala residues are primarily 
located in an orientation parallel with the micelle 
surface (Figure 5A).  
 
Figure 4: Distance from the micelle center to H
α
 atoms of M-Nleu11 
in DPC micelles obtained from PRE experiments. For structure 
calculations, these values were used as distance restraints with ±1 Å 
and a weight of 10% relative to NOE distance restraints. 
 
 
Figure 5: Structure ensembles of M-Nleu11 in DPC micelles with 
Nleu in the trans conformation. A: superposition of residues 2 to 10 
calculated without PRE restraints. B: superposition of residues 12-21 
calculated without PRE restraints. C: superposition of residues 2 to 
21 calculated with PRE restraints. Residues 1-9 are colored blue, 
residues 10-12 are colored green, and residues 13-21 plus the C-
terminal amide are colored red. The image was generated using the 
POVRay plugin to YASARA.33 
 
In order to understand why one of the maculatin 
analogs is found in only one conformation while the 
other has two conformations, the hypothetical 
structure of M-Nleu11 with cis-Nleu was calculated 
using all experimental data, but forcing Nleu 11 into 
the cis conformation. Figure 5 shows the orientation 
of the Nleu side chain in the trans and the 
hypothetical cis conformation. In the trans 
conformation, the side chain is buried in the micelle, 
and in the hypothetical cis conformation, the side 
chain would be exposed to the bulk water. 
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Figure 6: Comparison of M-Nleu11 trans (panel A, actual structure) 
and cis (panel B, hypothetical structure) in DPC micelles. Only the 
trans conformation was observed experimentally, the cis 
conformation was calculated by forcing ωNleu11 to 0°, otherwise the 
same restraints were used. The micelle is indicated by a semi-
transparent grey sphere with a radius of 22.7 Å. Both in the trans 
and the cis-structure, the charges at the N-terminus, Lys 8 and E19, 
are located at the micelle-water interface. So are the uncharged C-
terminal amide and His 12, while His 20 is immersed deeper into the 
micelle. Other residues at the micelle surface include Gly 4, Ala 7 
and Gly 15. The hydrophobic residues (Phe, Leu, Val, Ile) point 
towards the hydrophobic interior of the micelle. The peptoid 
residue, shown in green, points towards the solvent in the cis-
conformation, but towards the micelle interior in the trans 
conformation. The figure was created with YASARA
33
. 
 
Discussion 
Distinguishing between cis and trans conformation 
Initially, we attempted to solve the structures of both 
maculatin analogs in a solution of SDS. However, due 
to identical chemical shifts of H
α
 Ala10 and H
β
 Nleu11 
in M-Nleu11 bound to SDS, the presence of NOESY 
cross peaks between these atoms could not be 
established. Thus, a M-Nleu11 sample using DPC as 
the membrane mimic was used, where these peaks 
were resolved. In this sample, NOESY cross peaks 
from H
α
 Ala10 to the side chain of Nleu11 were 
present (see Figure 2), thus establishing that this 
analog contains a trans peptoid bond. The presence of 
a smaller amount of cis conformation cannot be ruled 
out completely, but additional spin systems were not 
present. Based on the signal-to-noise ratio of the 
strongest signals in the NOESY spectrum, we estimate 
that an eventually present cis conformation would be 
populated to less than 5%. When calculating the 
structure of M-Nleu11 in both the trans and cis 
conformation, the distance restraints from H
α
 Ala10 
to the Nleu11 side chain were the only ones that 
could not be fulfilled by both conformations. Very 
recently, a computational study of conformational 
preferences of peptomers was published, 
investigating the optimum backbone dihedral angles 
of an alanine residue preceding a peptoid residue (N-
methyl-glycine).
30
 The optimum angles are found 
within the regions adopted by pre-proline residues in 
the PDB database from the “Richardson top 8000” 
database.
31
 Figure 6 shows the ϕ/ψ angle distribution 
of the amino acid preceding the peptoid residue in 
the structures presented here. While the ϕ/ψ angles 
of trans-M-Nleu-11 are close to what can be expected 
for an amino acid preceding a peptoid, the angles do 
not fit for cis-M-Nleu-11, further substantiating the 
presence of a trans conformation.  
 
Figure 7: Ramachandran plot showing the distribution of the 
backbone torsion angles of the amino acid preceding the peptoid 
residue in maculatin-based peptomers: Ala 10 in M-Nleu-11 (blue) 
and His 12 in M-Nleu-13 (red). Circles denote cis conformation of 
the peptoid, crosses denote trans conformation of the peptoid. The 
black and white background shows the distribution of ϕ/ψ angles in 
amino acid residues preceding proline according to “Richardon’s top 
8000” database
31
.  
 
In M-Nleu13, one of the conformers was found to 
have a NOESY cross peak from H
α
 His12 to the Nleu13 
side chain, thus being the trans conformer. The other 
conformer had weak NOESY cross peaks from H
α
 
His12 to H
α
 Nleu13 (i.e. backbone to backbone), 
which should only be found in the cis conformer. 
 
Structural evaluation 
For both M-Nleu11 and M-Nleu13, the insertion of 
the peptoid monomer exerts a helix breaking effect. 
From the NOESY spectra this can be seen directly due 
to very weak or missing H
α
(i) – H
N
(i+3) NOESY cross 
peaks across the Nleu residue (Figure 1).  
Furthermore, the helix breaking effect is clearly visible 
from the structure ensembles of both analogs 
(without PRE-derived restraints), as they are 
characterized by well-defined helices at both termini 
with a very flexible region around the Nleu residue. 
The helix breaking effect is likely due to the steric 
repulsion between the Nleu side chain and the side 
chain of the previous residue as well as the loss of the 
hydrogen bonding H
N
 atom.  
 
After inclusion of the PRE-derived restraints for M-
Nleu11, the RMSD for the structure ensemble 
becomes quite low. Despite the lack of regular 
secondary structure around the peptoid residue, the 
position of the two terminal helices relative to each 
other is well defined as a consequence of the 
restraints to the micelle center. In α-helical cationic 
AMPs, the peptides fold into an amphipathic structure 
where the hydrophobic residues are inserted into the 
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membrane interior and the polar residues are 
interacting with the lipid head groups and the 
surrounding solvent.
28,32
 Therefore, the 20 structures 
of M-Nleu11 become very similar: the two helical 
ends of the molecule insert into the membrane mimic 
and lock the otherwise flexible region in place. This 
demonstrates the usefulness of PRE experiments to 
determine the insertion depth of each residue. 
Without this information, it is not possible to 
determine the orientation of the two helical ends of 
the molecule relative to each other (Figure 4, panel A 
and B). 
 
The structures of M-Nleu13 were solved without the 
use of PRE-derived restraints. The high degree of 
similarity of chemical shifts between the two 
conformers and resulting overlap of peaks made it 
impossible to obtain distinguishable relaxation rates. 
The lack of insertion depth data allows for highly 
variable orientations of the two helices relative to 
each other (Figure 7). Thus, only the fact that both 
ends fold into a helical structure, and that this 
molecule has an almost equal tendency to adopt a 
trans and cis conformation can be concluded. 
 
Figure 8: Structure ensembles of M-Nleu13 illustrating how the 
peptide folds into two α-helices for both the trans (A and B) and cis 
(C and D) conformation of Nleu13, as well as how flexible the 
middle region around the Nleu residue is. In panels A and C, the 
backbone structure of a single conformer from the bundle is 
displayed to illustrate the helical structure. Residues in blue are 
classified by YASARA 33 as helical whereas residues in cyan are not. 
In panels B and D, the entire bundle of 20 conformers is displayed as 
a superposition of residues 2-10. Residues 1-11 are colored blue, 
reisdues 12-14 are colored green, and residues 15-21 plus the C-
terminal amide are colored red. 
 
Why is the trans conformation preferred in M-
Nleu11? 
In the two maculatin analogs presented here, the 
Nleu residue was inserted at two different positions. 
One of these positions yields a molecule which 
prefers only a trans conformation of the Nleu residue, 
whereas the other has an equal tendency to adopt 
both cis and trans conformations of the Nleu residue.  
In the well-defined structures of M-Nleu11, a closer 
look on the Nleu residue shows that the side chain 
properties as well as the place of insertion of the 
peptoid monomer might be the determining factors 
for preferring the trans conformation: 
In M-Nleu11, the orientation of the peptide on the 
micelle-water interface is determined by the 
amphipathicity of the two helical segments. They will 
orient on the micelle surface such as is most favorable 
for them. Under these conditions, the Nleu side chain 
will be oriented towards the solvent in the cis 
conformation but towards the membrane interior in 
the trans conformation, as shown in Figure 5. This 
difference in orientation might explain why only the 
trans conformation is found for this peptide.  
 
Why are both cis and trans conformation present in 
M-Nleu13 
By following the argumentation for M-Nleu11, the 
reason why the cis and trans conformations are 
present in almost equimolar amounts in M-Nleu13 is 
that both conformations achieve an energetically 
equally favorable structure upon interaction with the 
membrane mimic. 
The Nleu side chain is located on the opposite side of 
the helix in M-Nleu13, where the backbone of the 
residue in wild-type maculatin (Val) is inserted into 
the hydrophobic interior of the micelle. It is possible 
that both the cis and trans conformation allows for 
the hydrophobic Nleu side chain to be inserted into 
the hydrophobic interior of the micelle, but we cannot 
conclude on this based on structures without PRE-
derived constraints. In addition, Nleu-13 follows the 
bulky His-12, while Nleu-11 follows the less bulky Ala-
10. Distances between side chain atoms of a peptoid 
and the side chain atoms of its preceding residue are 
generally shorter for the trans conformer. Figure 8 
shows the distribution of shortest inter-sidechain 
distances in all 20 structures of all four molecules 
calculated. Trans-M-Nleu-13 shows distances <2.4 Å 
(twice the VdW radius of hydrogen), leading to steric 
clashes, while cis-M-Nleu-13 displayed a wide range 
of distances both favorable and unfavorable. This 
might also be a reason for this molecule to partly 
adopt a cis conformation. Very short distances are 
also present in trans-M-Nleu-11, but to a lesser 
extent. 
 
Figure 9: Shortest distance found between any two hydrogen atoms 
of the peptoid side chain and the preceding peptide side chain in all 
20 calculated structures of both peptomers studied in their cis and 
trans conformations. The Van der Waals radius of hydrogen is 1.2 Å, 
thus making distances closer than 2.4 Å energetically unfavorable. 
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Conclusion 
The insertion of a peptoid monomer into an α-helical 
AMP disrupts the helix. Inserting the Nleu residue can 
result in both a cis and trans conformation of the 
peptide. The conformations can be determined 
experimentally by the presence of NOESY cross peaks 
from H
α
 of the preceding residue to either the side 
chain H
β
 (trans) or backbone H
α
 (cis) of the peptoid 
residue. As the side chain of the peptoid monomer is 
shifted counter-clockwise in the helical wheel, 
hydrophobic peptoid monomers should be placed on 
the left-handed side of the helical wheel (looking 
down the helical axis from the N-to the C-terminus, 
with the helix oriented such that the membrane 
interior points downwards) near the middle of 
maculatin in order for only the trans conformer to be 
present. When inserting Nleu on the right-handed 
side of the helical wheel near the middle of an AMP, 
both the cis and trans conformers can be present. In 
addition, trans conformers can be favored by not 
placing the peptoid after a bulky residue, as bulky 
residues favor the cis conformation in subsequent 
peptoids. Furthermore, we have demonstrated the 
usefulness of PRE experiments for determining the 
global structure of peptomers bound to micelles. 
 
Acknowledgements 
This project was conducted in the framework of the 
Danish Center for Antibiotic Research and 
Development (DanCARD) financed by The Danish 
Council for Strategic Research (grant no. 09–067075). 
We thank the Centre for Biomolecular Magnetic 
Resonance, Frankfurt, Germany, for access to NMR 
equipment and Dr. Frank Löhr for expert assistance. 
The NMR laboratory at Aalborg University is 
supported by the Obel, SparNord and Carlsberg 
Foundations. 
 
 
References 
1. Miller SM, Simon RJ, Ng S, Zuckermann RN, Kerr JM, 
Moos WH (1994) Proteolytic studies of homologous 
peptide and N-substituted glycine peptoid oligomers. 
Bioorg Med Chem Lett 4:2657–2662. 
2. Godballe T, Nilsson LL, Petersen PD, Jenssen H 
(2011) Antimicrobial β-peptides and α-peptoids. 
Chem Biol Drug Des 77:107–16. 
3. Meinike K, Hansen PR (2009) Peptoid analogues of 
anoplin show antibacterial activity. Protein Pept Lett 
16:1006–1011. 
4. Pripotnev S, Won A, Ianoul A (2010) The effects of 
L- to D-isomerization and C-terminus deamidation on 
the secondary structure of antimicrobial peptide 
Anoplin in aqueous and membrane mimicking 
environment. J Raman Spectrosc 41:1645–1649. 
5. Olsen CA, Bonke G, Vedel L, Adsersen A, Witt M, 
Franzyk H, Jaroszewski JW (2007) Alpha-peptide/beta-
peptoid chimeras. Org Lett 9:1549–52. 
6. Chongsiriwatana NP, Patch JA, Czyzewski AM, 
Dohm MT, Ivankin A, Gidalevitz D, Zuckermann RN, 
Barron AE (2008) Peptoids that mimic the structure, 
function, and mechanism of helical antimicrobial 
peptides. Proc Natl Acad Sci U S A 105:2794–9. 
7. Simon RJ, Kania RS, Zuckermann RN, Huebner VD, 
Jewell DA, Banville S, Ng S, Wang L, Rosenberg S, 
Marlowe CK, et al. (1992) Peptoids: a modular 
approach to drug discovery. Proc Natl Acad Sci 
89:9367–9371. 
8. Moure A, Sanclimens G, Bujons J, Masip I, Alvarez-
Larena A, Pérez-Payá E, Alfonso I, Messeguer A (2011) 
Chemical modulation of peptoids: synthesis and 
conformational studies on partially constrained 
derivatives. Chem Eur J 17:7927–39. 
9. Ostergaard S, Holm A (1997) Peptomers: a versatile 
approach for the preparation of diverse combinatorial 
peptidomimetic bead libraries. Mol Divers 3:17–27. 
10. Robey FA, Kelson-Harris T, Roller PP, Robert-
Guroff M (1995) A helical epitope in the C4 domain of 
HIV glycoprotein 120. J Biol Chem 270:23918–21. 
11. Fowler SA, Stacy DM, Blackwell HE (2008) Design 
and synthesis of macrocyclic peptomers as mimics of 
a quorum sensing signal from Staphylococcus aureus. 
Org Lett 10:2329–32. 
12. Murugan RN, Park J-E, Lim D, Ahn M, Cheong C, 
Kwon T, Nam K-Y, Choi SH, Kim BY, Yoon D-Y, et al. 
(2013) Development of cyclic peptomer inhibitors 
targeting the polo-box domain of polo-like kinase 1. 
Bioorg Med Chem 21:2623–34. 
13. Ovadia O, Linde Y, Haskell-Luevano C, Dirain ML, 
Sheynis T, Jelinek R, Gilon C, Hoffman A (2010) The 
effect of backbone cyclization on PK/PD properties of 
bioactive peptide-peptoid hybrids: the melanocortin 
agonist paradigm. Bioorg Med Chem 18:580–9. 
14. Lee B-C, Zuckermann RN (2011) Protein side-chain 
translocation mutagenesis via incorporation of 
peptoid residues. ACS Chem Biol 6:1367–74. 
15. Song YM, Park Y, Lim SS, Yang S-T, Woo E-R, Park I-
S, Lee JS, Kim J Il, Hahm K-S, Kim Y, et al. (2005) Cell 
selectivity and mechanism of action of antimicrobial 
model peptides containing peptoid residues. 
Biochemistry 44:12094–106. 
16. Zhu WL, Song YM, Park Y, Park KH, Yang S-T, Kim J 
Il, Park I-S, Hahm K-S, Shin SY (2007) Substitution of 
the leucine zipper sequence in melittin with peptoid 
53
54 
 
residues affects self-association, cell selectivity, and 
mode of action. Biochim Biophys Acta 1768:1506–17. 
17. Patch JA, Barron AE (2003) Helical peptoid mimics 
of magainin-2 amide. J Am Chem Soc 125:12092–3. 
18. Ryge TS, Frimodt-Moller N, Hansen PR (2008) 
Antimicrobial activities of twenty lysine-peptoid 
hybrids against clinically relevant bacteria and fungi. 
Chemotherapy 54:152–6. 
19. Ryge TS, Hansen PR (2006) Potent antibacterial 
lysine-peptoid hybrids identified from a positional 
scanning combinatorial library. Bioorg Med Chem 
14:4444–51. 
20. Rozek T, Waugh RJ, Steinborner ST, Bowie JH, 
Tyler MJ, Wallace JC (1998) The Maculatin peptides 
from the skin glands of the tree frogLitoria 
genimaculata: a comparison of the structures and 
antibacterial activities of Maculatin 1.1 and Caerin 
1.1. J Pept Sci 4:111–115. 
21. Chia BC, Carver JA, Mulhern TD, Bowie JH (2000) 
Maculatin 1.1, an anti-microbial peptide from the 
Australian tree frog, Litoria genimaculata solution 
structure and biological activity. Eur J Biochem 
267:1894–908. 
22. Ambroggio EE, Separovic F, Bowie JH, Fidelio GD, 
Bagatolli LA (2005) Direct visualization of membrane 
leakage induced by the antibiotic peptides: maculatin, 
citropin, and aurein. Biophys J 89:1874–1881. 
23. Zuckermann RN, Kerr JM, Kent SBH, Moos WH 
(1992) Efficient method for the preparation of 
peptoids [oligo(N-substituted glycines)] by 
submonomer solid-phase synthesis. J Am Chem Soc 
114:10646–10647. 
24. Chann WC, White PD Fmoc Solid Phase Peptide 
Synthesis: A Practical Approach. Oxford Univ. Press; 
2000. 
25. Hwang TL, Shaka AJ (1995) Water Suppression 
that Works. Excitation Sculpting Using Arbitrary 
Wave-Forms and Pulsed-Field Gradients. J Magn 
Reson Ser A 112:275–279. 
26. Keller R The computer aided resonance 
assignment tutorial. 1 st edn. Goldau (Switzerland): 
CANTINA Verlag; 2004. 
27. Shen Y, Delaglio F, Cornilescu G, Bax A (2009) 
TALOS+: a hybrid method for predicting protein 
backbone torsion angles from NMR chemical shifts. J 
Biomol NMR 44:213–223. 
28. Franzmann M, Otzen D, Wimmer R (2009) 
Quantitative Use of Paramagnetic Relaxation 
Enhancements for Determining Orientations and 
Insertion Depths of Peptides in Micelles. 
Chembiochem 10:2339–2347. 
29. López-Méndez B, Güntert P (2006) Automated 
protein structure determination from NMR spectra. J 
Am Chem Soc 128:13112–22. 
30. Butterfoss GL, Drew K, Renfrew PD, Kirshenbaum 
K, Bonneau R (2014) Conformational Preferences of 
Peptide-Peptoid Hybrid Oligomers. Biopolymers in 
press. 
31. Richardson JS, Keedy DA, Richardson DC “The 
Plot” Thickens: More Data, More Dimensions, More 
Uses. In: Bansal M, Srinivasan N, editors. Biomolecular 
Forms and Functions. A Celebration of 50 Years of the 
Ramachandran Map. Singapore: World Scientific; 
2013. pp. 46–61. 
32. Vad B, Thomsen LA, Bertelsen K, Franzmann M, 
Pedersen JM, Nielsen SB, Vosegaard T, Valnickova Z, 
Skrydstrup T, Enghild JJ, et al. (2010) Divorcing folding 
from function: How acylation affects the membrane-
perturbing properties of an antimicrobial peptide. 
Biochim Biophys Acta - Prot Proteomics 1804:806–
820. 
33. Krieger E, Koraimann G, Vriend G (2002) 
Increasing the precision of comparative models with 
YASARA NOVA--a self-parameterizing force field. 
Proteins 47:393–402.  
54
55 
 
 
 
Supplementary Material 
 
 
Figure S1: A: Chemical structure of Nleu with atom nomenclature used. B: Illustration of cis and trans isomerism of 
Nleu inserted into a peptide chain. 
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Figure S2: Contour plots showing the distances between atoms of the peptoid residue i and the residue preceding the 
peptoid residue (i-1), depending on the cis/trans conformation of the peptoid bond and other dihedral angles. 
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9. Further results and discussion 
Circular Dichroism9 
All peptides studied in this work were measured by circular dichroism (CD) prior to activity 
assays and NMR measurements. CD measurements were performed in the wavelength range 
190-260nm on a Chirascan plus spectropolarimeter using a peptide concentration of 50µM 
dissolved in 2 mM phosphate buffer, pH 6.5 at 20˚C. The pathlength through the cuvette was 
1mm, and DPC and/or SDS (both from Avanti Polar Lipids) was gradually added until the CD 
curve no longer changed upon further addition of lipid (titration steps varied between sample 
types). For all samples which were measured with both DPC and SDS, no differences in CD 
profiles were observed. 
The purpose of these measurements was to see whether secondary structure was induced in the 
peptides upon interaction with the zwitterionic (DPC) and anionic (SDS) lipids, before using 
either of these membrane mimics in the NMR samples. 
All peptides presented in the two articles showed an induced secondary structure (α-helical) 
upon binding to the membrane mimics. Many of these peptides showed an isosbestic point, 
displaying a direct transition from the unstructured conformation in 2mM phosphate buffer to 
the structured conformation upon binding to the micelles following a two-state model. An 
example of this is given in Figure 9.1. However, a peptide such as 5F8W did not have an 
isosbestic point as shown in Figure 9.2, and already showed some degree of secondary structure 
before adding lipids to the sample. This is in accordance with the observation in Paper 1, where 
it was found that 5F8W has a strong tendency to self-aggregate. The CD signal of 5F8W never 
becomes purely α-helical, despite the fact that this structure was solved via NMR and found to 
fold into a complete α-helix. Another peptide which has been discussed a lot in paper 1 is 5W, 
and its CD spectra are shown in Figure 9.3. Like 5F8W, this peptide has some degree of 
secondary structure before the addition of lipids, but oppositely to 5F8W this peptide shows a 
high degree of helicity upon addition of lipid. The information obtained from CD cannot be used 
to predict activity as such, but it is noteworthy that the peptides with the highest degree of 
hemolysis show a different CD profile from the majority of tested peptides. CD might provide a 
fast way to qualitatively determine their hemolytic activity (unspecific membrane interaction) 
and whether the peptide has a tendency for self-aggregation. 
 
Figure 9.10: CD spectra of 50μM anoplin in 2mM phosphate buffer, pH 6.5, 20°C at various concentrations of DPC. 
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Figure 9.2: CD spectra of 50μM 5F8W in 2mM phosphate buffer, pH 6.5, 20°C at various concentrations of DPC. 
 
Figure 9.3: CD spectra of 50μM 5W in 2mM phosphate buffer, pH 6.5, 20°C at various concentrations of DPC. 
 
In relation to the work with peptide/peptoid hybrids several smaller peptides were investigated, 
where a N-(indol-3-yl-ethyl)-glycine was inserted into position 3, 5, and 9 in anoplin. For these 
hybrids, the CD spectra showed a significant loss of structure compared to anoplin, and the 
structure was only determined for the analogue with peptoid monomer in position 5. The CD 
spectrum for this anoplin analogue is shown in Figure 9.4. Despite the poor quality of the CD 
spectrum, it can be seen that a partly helical profile is present at the high SDS concentrations 
(minima around 208nm and 220nm).  
 
Figure 9.11: CD spectra at various SDS concentrations of the anoplin analogue with an N-(indol-3-yl-ethyl)-glycine 
inserted in position 5. The spectra are of poor quality because they were recorded on an older CD 
spectropolarimeter (Jasco J-715). 
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Structural studies of peptides containing peptoid monomers 
Anoplin-peptoid chimeras 
The structure of the anoplin analogue containing N-(indol-3-yl-ethyl)-glycine in position 5 was 
determined using NMR. One of the calculated structures is shown in Figure 9.5. The peptide 
structure was not easily obtained. Firstly, the peptide was split into a major and minor 
conformer. Secondly, spin systems from the N-terminal part of the analogue were weak (some 
not even found) while the spin systems of the C-terminus were strong. Thirdly, exchange peaks 
between the two conformers were found showing that a transition between the two conformers 
takes place. In general, HN for residue 1 is never observed in the NMR spectra of peptides, due 
to fast exchange of the proton with the water protons. For a flexible terminus this can also be 
the case for several of the following residues due to mobility reasons. In this peptide, HN for 
Leu2 could not be seen, and the HA peaks were likely hidden under some of the stronger LEU 
spin systems. Furthermore, there is no HN on peptoid monomers. It has on several occasions 
been observed that the insertion of a peptoid monomer can cause the HN signal to disappear 
from nearby residues. In this analogue, this was the case for Ile6. Due to all these reasons, only a 
few classical NOEs expected for α-helices were found for the C-terminal part of the anoplin 
analogue (residues 6 to 10), and only very sparse NOEs at all in the N-terminal part (residues 1-
5). This can be seen from the sequence plot in Figure 9.5. Consequently, the final structure 
(calculated from the major solution conformer in the trans configuration) displays a flexible N-
terminus and an α-helical C-terminus (Figure 9.6), thus explaining why the CD spectrum of this 
analogue showed a high certain degree of α-helix. This means that small peptides can maintain 
at least some of their secondary structure upon insertion of a helix-disrupting peptoid monomer. 
However, this is likely dependent on the side chain properties and site of insertion, as concluded 
in Paper 2. The inability of forming an α-helix on the N-terminal side of the peptoid monomer 
was the onset for studying the structural impacts of inserting a peptoid monomer in a much 
longer helical AMP (maculatin). 
  
Figure 9.5: Sequnce plot of the anoplin analogue containing N-(indol-3-yl-ethyl)-glycine in position 5 (unlabeled in 
the sequence). 
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Figure 9.6: NMR structure of the anoplin analogue which has an N-(indol-3-yl-ethyl)-glycine  inserted in position 5. 
The backbone and peptoid monomer is shown in sticks, and the standard amino acids with side chains are shown in 
lines. The N-terminus is to the left. No regular secondary structure is found for the N-terminus, but an α-helical 
structure is observed for the C-terminus. Structure is visualized via PYMOL. 
 
Maculatin-peptoid chimeras 
In the study of the maculatin-peptoid hybrids, 4 analogues were originally designed and 
synthesized. The Nleu monomer was inserted into positions 9, 10, 11, and 13. 
Maculatin-G15 GLFGVLAKVAAHVVGAIAEHF-NH2 
M-Nleu13  GLFGVLAKVAAHNleuVGAIAEHF-NH2 
M-Nleu11  GLFGVLAKVANleuHVVGAIAEHF-NH2 
M-Nleu10  GLFGVLAKVNleuAHVVGAIAEHF-NH2 
M-Nleu9  GLFGVLAKNleuAAHVVGAIAEHF-NH2 
 
In all these analogues, Nleu was inserted in place of aliphatic amino acids (Ala or Val) in the 
center of the maculatin sequence. These sites of insertion were chosen because we wished to 
see if the same structural motif would occur regardless of insertion site, because we wished to 
make the substitutions relatively conservative, and because the peptoid monomer should be 
located so it allows for helix formation on both sides of the insertion site. 
Maculatin-G15 was shown by Franzmann44 to fold into a continuous α-helix throughout the 
whole peptide. By using his NMR spectra, the PRE data were revised and the final insertion 
depth data (Figure 9.7) were used for obtaining an experimentally derived helical wheel plot, 
similar to the ones obtained for anoplin in Paper 1. The experimentally derived helical wheel plot 
is shown in Figure 9.8 together with the theoretical helical wheel for maculatin-G15. 
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Figure 9.7: Insertion depth profile of maculatin-G15. 
 
 
Figure 9.8: Experimentally derived and theoretical helical wheel projection of maculatin-G15 oriented such that 0 
degrees is the direction towards the micelle interior. Hydrophobic residues are in blue, polar and Gly residues in 
red, and Ala residues in green. The purple line in the theoretical helical wheel indicates that both a polar and 
hydrophobic residue have this orientation. In the experimentally derived helical wheel projection, the sites of 
insertion of peptoid monomers have been shown by the peptide analogue names. 
  
By now, we have realized that the helical wheel plot is not a very accurate model, as the side 
chain properties can distort the backbone of the helix away from the 100 degrees per residue, 
thus compressing or stretching the helix. This is also the case for maculatin, where the actual 
structure is more extended than predicted by the helical wheel model. This is most easily seen 
by comparing the orientations of for instance G4 and G15 or H12 and E19 between the two 
helical wheel plots. 
The use of a peptoid monomer will displace the side chain of that residue with about 33 degrees 
counterclockwise, which means that both Nleu10 and Nleu11 will have their side chain oriented 
further towards the micelle interior, whereas both Nleu9 and Nleu13 will have their side chain 
oriented further towards the micelle exterior (if the overall structure and orientation of the 
peptide does not change). 
The structures were only succesfully solved for M-Nleu11 and M-Nleu13, due to poor spectra 
quality of the M-Nleu9 and M-Nleu10 samples. During the structural work on M-Nleu9 and M-
Nleu10 it was however clear that M-Nleu9 consists of two conformers similarly to M-Nleu13 in 
the presence of SDS-micelles and that M-Nleu10 consists of only one conformer similarlu to M-
Nleu11. This confirms the statement in Paper 2 that insertion of the hydrophobic peptoid 
monomer, Nleu, on the left-handed side of the helical wheel plot allows for one very beneficial 
conformation (trans for M-Nleu-11 and unknown for M-Nleu10), whereas both cis and trans 
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conformation are equally favorable when inserting the peptoid monomer on the right-handed 
(M-Nleu9 and M-Nleu13). 
It would be desireable to know whether the trans conformer is in general the most beneficial 
conformation for a peptoid monomer inserted into an α-helical AMP, and if the orientation of 
the Nleu side chain in the cis and trans conformation is always as found for the trans and 
hypothetical cis conformer of M-Nleu11 in paper 2. If this is the case, the presence of only one 
conformation in M-Nleu10 and M-Nleu11 would be explained by the favorable interaction of the 
hydrophobic side chain in trans conformation with the membrane interior. At the same time, it 
would also explain why the cis conformation is present in M-Nleu9 and M-Nleu13, as the trans 
conformation would orient the hydrophobic side chain away from the micelle interior, thus 
making the cis conformer relatively more favorable.  
A verification of these assumptions would yield a useful guideline about where to insert peptoid 
monomers (with non-rigid side chains) in order for only one structure to occur (hydrophobic side 
chains on the left-handed side and hydrophilic on the right-handed side). However, a more 
comprehensive structural investigation is required, as well as studies on how the insertion of the 
peptoid monomers affect the activity of the AMPs. 
α-peptide-β-peptoid chimeras 
Some initial work was also done on peptidomimetics consisting of a sequence with alternating α-
amino acids and β-peptoid monomers. One of these were the octamer shown in Figure 9.9. 
 
Figure 9.9: Chemical structure of the octamer used in the study of α-peptide-β-peptoid chimeras. 
 
This work proved to be of such complexity, that the attempts to solve their structures were 
stopped. The reason was that the NMR spectra showed such a high amount of different 
conformers, that the spins systems could not be separated. An accurate amount of conformers 
could not even be determined, but theoretically, each β-peptoid monomer could take 2 
conformations, leading to a total of 16 different conformations for this compound based on 
cis/trans isomerism. 
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10. Discussion of the usefulness of 
commonly used SAR parameters 
As stated in the introduction, some of the usual parameters investigated in relation to the 
activity of cationic α-helical AMPs are hydrophobicity, mean hydrophobicity, hydrophobic 
moment/amphipathicity, charge, helicity, and polar angle. These parameters have been 
suggested by various authors and more or less accepted by the scientific community. At one 
point of my work, these structural parameters were tested against our set of peptides to see if 
they could explain the observed activities, but no useful correlations were found. For the anoplin 
analogues, we also included parameters such as tilt of the helix, rotation of the helix, and 
average insertion depth to no avail. We thus started from scratch and came to the parameters 
and conclusions presented in Paper 1. Based on that work I took another look at these structural 
parameters, and I now believe that these parameters should either be revised or discarded, as 
their definitions are stated without proper restrictions to their use or they are simply not 
parameters relevant for the activity of this class of AMPs. 
Helical wheel 
The helical wheel model has been used for more than half a century45, and is an excellent way to 
inspect the properties of α-helical structures. In the work of helical AMPs, this model has been 
used extensively in the design of improved analogues and even to calculate structural 
parameters such as hydrophobic moment and polar angle. However, the helical wheel is only a 
model. It does not necessarily match the actual helical structure of a given peptide. In this work, 
we have shown that side chains can be oriented quite differently from the theoretical 
orientation, and that the compactness of the helix is influenced by the side chain distribution 
upon AMP interaction with a membrane mimic. It is common knowledge, that helices can be 
compressed (310 helix), and we showed experimentally that the helix of maculatin was extended 
slightly throughout the helix. This means that the helical wheel model becomes less accurate 
with increasing length of the AMP under study.  
Based on this, the structural parameters based on the helical wheel will be prone to error, and 
prediction of beneficial substitution sites might be based on false assumptions. The longer the 
peptides, the larger the errors can be. Furthermore, the helical wheel model is difficult to use in 
relation to helices containing proline residues (or even D-amino acids), as the kink they induce 
makes it difficult to predict the orientation of the two helical parts relative to each other (e.g. 
wild type maculatin). 
With the PRE method used in our study42, the actual structure of a helix can be determined 
experimentally, and this should (in my opinion) be done instead of relying only on the helical 
wheel model. 
Hydrophobicity 
Hydrophobicity is used in two ways: the sum of hydrophobicities of all residues and the mean 
hydrophobicity of all residues. The sum of hydrophobicities is only meaningful when comparing 
peptides of the same length whereas the mean hydrophobicity can (in theory) be used to 
compare peptides of various lengths.  
The first issue regarding hydrophobicity is that there are so many scales for it, and they do not 
rank the amino acids in the same order46. In order to make use of hydrophobicity as a 
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parameter, it must be standardized which scale to use, and this scale should be expanded to 
include all non-classic amino acids as well, as this is a severe limitation in some of these scales. 
This expansion is important, as more and more work using non-classic amino acids is being 
performed in the attempt to make peptides more resistant to degradation. 
The second issue regarding hydrophobicity is that it can be changed in different ways. In paper 1, 
the insertion of aromatic compounds in various positions of anoplin showed that it makes a huge 
difference whether they were inserted instead of a water-interacting residue or a lipid head-
group interacting residue. The latter would result in a much higher loss of selectivity due to the 
ability of that residue to orient itself inward in the micelle and interact with the hydrophobic 
interior. Our experimental data are very clear on this point, but they are based on a small set of 
peptides and should be documented further (see perspectives). 
Due to the positional difference in activity and selectivity of an inserted hydrophobic residue, 
the parameter hydrophobicity should be restated to “hydrophobicity of the hydrophobic face”, 
and then the effect of insertion of hydrophobic/non-polar residues pointing towards the bulk 
water (solvent) should be investigated as a separate concept.  
This would perhaps yield a parameter useful for comparing peptides of different lengths as well. 
The results of paper 1 showed that a less strong hydrophobic face is required as the length of 
the helix increases. i.e. the mean hydrophobicity of the hydrophobic face should be reduced as 
the length of the peptide increases. Due to the very limited set of peptides in our study, it is not 
yet possible to determine this relationship quantitatively. A useful design of peptides should 
include a hydrophilic face which has a conserved charge and polarity per extension, after which 
the strength of the hydrophobic face should be modulated by choosing between Phe, Trp, Ile, 
Leu, Val, Ala, and Gly at various positions. This will allow for determination of the useful range of 
hydrophobicity of the hydrophobic face required to achieve activity (hydrophobic enough) 
without significant loss of selectivity (too high hydrophobicity). It should be noted that this 
hydrophobicity window only can yield a range of useful hydrophobicities, as our data and other 
studies have shown that the distribution of the hydrophobicity also is important.  
Mean hydrophobicity 
The mean hydrophobicity has (until now) been a measure which could be used to compare 
peptides of different lengths, as opposed to the hydrophobicity which is just a summation. 
However, the mean hydrophobicity is influenced by changes on both the hydrophilic- and the 
hydrophobic face of an AMP, and we have shown in Paper 1 that the hydrophobicity/polarity of 
these can be modulated with different effects. Thus, the mean hydrophobicity cannot be used as 
a parameter in itself as it depends on the contribution from two, more fundamental, 
parameters.  It might be appropriate to defined a parameter like “average hydrophobicity of the 
hydrophobic face”, which might be useful when comparing peptides of different lengths. 
However, as shown and discussed in Paper 1, the degree of hydrophobicity of the hydrophobic 
face should be reduced when increasing the length of an AMP, thus requiring such a parameter 
be some sort of peptide-length-function.  
Hydrophobic moment/amphipathicity 
The hydrophobic moment is a complex descriptor, which is dependent on the properties and 
orientation (in the helical wheel model) of the individual amino acids30. The parameter 
hydrophobic moment is also referred to as the amphipathicity of the helix. It is the vectorial sum 
of the hydrophobicities of each residue, where the vectorial directions are taken from the helical 
wheel model. The issue regarding the differences between the various hydrophobicity scales 
mentioned under the hydrophobicity section is also applicable here. The strength of the 
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hydrophobic moment (as a structural parameter) is that it takes into account whether a 
hydrophobic residue is oriented towards membrane interior or bulk solvent. It is easy to design 
studies, where this parameter can be useful (this is actually the case for the main part of the 
peptides published in paper 1), but the parameter cannot be used on all studies as it depends on 
several other parameters. 
 In order to increase the hydrophobic moment of a peptide, three possibilities exist, but 
commonly only two of them are used: either the polarity of a hydrophilic residue is increased 
(shown in paper 1 not to strongly increase hemolytic activity) or the hydrophobicity of a 
hydrophobic residue is increased (strongly increases hemolytic activity). The third (and mostly 
unexplored) way is to swap residues or atoms between side chains on either the hydrophobic- or 
hydrophilic face in a way which directs the most polar and most hydrophobic residues oppositely 
of each other (shown in paper 1 under “modulation of hydrophobicity profile” to have quite an 
impact on activity). The hydrophobic moment does not take into consideration the distribution 
of the various residues along the helical axis. Thus, it cannot differentiate between a peptide 
with an even distribution of hydrophobic resides and a peptide which has one strongly 
hydrophobic residue (lipophilic anchor) and correspondingly weaker hydrophobic residues on 
the hydrophobic face.  This was shown in paper 1 to yield different activities. When these three 
types of alterations yield distinct changes in activity and selectivity, the hydrophobic 
moment/amphipathicity of a helix should NOT be used as a structural parameter in SAR studies. 
Much in line with the parameters defined for hydrophobicity, amphipathicity should be divided 
into describing the hydrophilic and hydrophobic faces separately, as well as observing each turn 
of the helix separately. 
I cannot think of one parameter which can integrate these three considerations into one 
parameter. It would perhaps be useful to consider the faces separately, where the hydrophobic 
face is already considered in “hydrophobicity of the hydrophobic face” and its opposite was 
termed “polarity of the hydrophilic face”. Both of these showed correlations with activity and 
selectivity in the study of paper 1, but neither takes into consideration how to distribute the 
hydrophobicity and polarity along the helical axis.  
Charge 
An increase in charge has often been found to increase antimicrobial activity without increasing 
cytotoxicity. In some papers, the increase in charge has even been found to increase selectivity 
by reducing the hemolytic activity1,2,5. However, a few papers5,21 have been cited for showing 
that an increase in charge will not always be beneficial, and that it can increase the hemolytic 
activity to increase the charge above a certain point. These papers do not show that an increase 
in charge for a given peptide is unfavorable. In the work done by Bessalle et al., the increase in 
charge is done by extending the AMP of interest by a poly cationic segment, and thus the 
modified peptides cannot be compared to the original peptide21. In the work of Dathe et al., the 
increase in charge is followed by an increase in the hydrophobicity of the hydrophobic face 
(hydrophobicity of the non-cationic helix surface) of the AMP of interest in order to maintain 
hydrophobicity, hydrophobic moment, and polar angle (angle subtended by cationic residues) 5. 
Thus, the increase in hemolytic activity is in my opinion purely a result of the hydrophobicity of 
the hydrophobic face, which is in accordance with their observations. As such, when increasing 
the polarity of the hydrophilic face of an α-helical AMP without changing its length, I have found 
no contradictions to the statement: An increase in charge will increase the activity of the AMP. 
Whether the increase in charge can increase selectivity of a given α-helical AMP is still uncertain 
to me. In our experiments, where the increase in charge does not influence the hydrophobicity 
of the hydrophobic face, selectivity is not improved. Thus, I believe that an increase in charge or 
polarity will only increase the selectivity of a given AMP if it replaces a residue which was 
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contributing to the hydrophobicity of the hydrophobic face. The results presented in the study of 
Dathe et al.5 can all be explained by this, but I cannot say for sure whether the increase in 
selectivity (by reduction of hemolytic activity) is caused solely by removal of hydrophobic 
residues that are able to interact with the membrane interior. 
Helicity 
Helicity is an often mentioned parameter in relation with SAR studies, and quite a lot of 
conclusions have been drawn on the basis of helicity measurements5,21,28,47–52. The most 
common conclusion is that the increase in helicity correlates with antimicrobial activity to some 
degree, and highly with cytotoxicity52. This is also the case for studies on anoplin28,49–51. 
 
First of all, I do not think that the helicity measurements conducted in many studies actually 
measures the degree of helix, a peptide adopts in the presence of a biological membrane. When 
measuring the helicity using CD, the commonly used and helix inducing solvent, TFE, does not 
yield information of how much a given peptide will fold into a helix upon interaction with actual 
membranes52. The use of DPC or SDS is a much more viable option, although the lipid 
composition and curvature of these micelles differs significantly from that of an actual 
membrane.  
The question is; what do these helicity measurements actually tell us about? 
The reported helicities are most likely a measure of the peptide’s affinity for inserting into a 
membrane, which is dependent on the hydrophobicity of the hydrophobic face.  
An increase in helicity is often associated with an increase in hydrophobicity of the peptide or an 
increased retention time on the HPLC, while a decrease in helicity is often associated with 
disrupting the secondary structure of otherwise perfectly amphipathic helices by the use of for 
instance D-amino acids 5,28,47,51,52. The effects of increasing the hydrophobicity of a peptide have 
already been discussed. The retention time on a HPLC column depends on how large a 
hydrophobic interaction that can take place between the peptide and the carbon chains in the 
column. The size of this interaction would be greatest when most of the hydrophobic residues in 
the peptide are bound to the carbon chains, which for amphipathic helical AMPs would be when 
the hydrophobic face of the helix is bound to the column interior. The disruption of the 
secondary structure of such a peptide would then prevent the formation of the strongest 
possible hydrophobic face, thus lowering the hydrophobic interaction within the HPLC column. 
 
This means that the observed correlation between helicity and hemolytic activity is most likely 
caused by the increase in hydrophobicity of the hydrophobic face (increased affinity for the 
hydrophobic interior of all membranes). The correlation sometimes observed between helicity 
and activity is caused by this as well, as an increase in hydrophobicity of the hydrophobic face 
will also increase the activity against the bacterial membranes at the same time as it increases 
the affinity against erythrocytes. This also explains why increase in helicity has not been 
reported to correlate with increased selectivity, as an increase in hydrophobicity of the 
hydrophobic face will eventually remove all selectivity of the AMP. 
 
The following walkthrough of the published data on anoplin serves as a great example to 
substantiate my claim that the measured helicities does not say anything about the actual 
structure of a peptide in the presence of a biological membrane. 
 
Helical content of anoplin 
Until now, several reports regarding the helical content of anoplin have been given in literature, 
and the values are summarized in Table 11.1. Furthermore, molecular dynamics (MD) 
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simulations indicated that the anoplin helix involves residues 4-9 49 and 4-7 50. Furthermore, it 
has been stated that “the helical content of peptides like anoplin cannot exceed 50-60% due to 
the terminal effects” 51. 
Table 11.1: Reported helical content of anoplin 
Spectroscopic method Helical content [membrane mimic] 
CD[a] 49 45% [30% TFE] 
65% [160μM SDS] 
CD[a] 28 77% [50% TFE] 
CD[a] 50 32-43% [40% TFE] 
32-43% [8mM SDS] 
Resonance Raman51 9% [50% TFE] 
 
[a] CD is known to have limited sensitivity for short helical 
sequences51. 
In opposition to these data, all anoplin analogues studied by NMR in the presence of 
approximately equimolar amounts of DPC micelles (150mM DPC to 3mM AMP) were shown to 
fold into a regular -helix for residue 2-10 plus the C-terminal amide while the N-terminal 
glycine residue was flexible (>90% helicity). Despite the differences in the experimental 
conditions, these data are quite contradictory to previous results regarding the helicity of 
anoplin. 
This is why I question the classical way to measure helicity: The degree of helicity obtained for 
solutions of TFE or lipid concentrations of SDS and DPC below their CMC values are not 
comparable to the degree of helicity that will be induced upon interaction with actual 
membranes. These helical AMPs fold into their amphipathic structure due to the greatly 
favorable condition where the hydrophobic side chains are burried within a membrane and 
polar side chains interacting with lipid head groups or solvent. This condition is not fulfilled for 
peptides interacting with the isotropic solvent, TFE, or with individual surfactant molecules. In 
our NMR samples, the surfactant concentrations are more than 100 times the cmc, and the NMR 
data provide clear evidence for the presence of an  -helix ranging from residue 2 to 10.  
In relation to the above discussion, it should be noted, that a result like “50% helicity” only 
means that 50% of the peptide bonds are in a helical structure. This could mean that 50% of the 
residues in each peptide are folded into a helix, but it could also mean that 50% of the peptide 
molecules in the ensemble are fully helical (e.g. bound to a membrane), while 50% are random 
coil (e.g. not bound to a membrane). It is not possible to distinguish between these two 
situations (and anything in between) using CD. The helicities obtained from CD are most likely 
just a measure of the propensity of the AMP to interact with a membrane. This would fit with 
the observed correlations between helicity and cytotoxicity – the more helicity, the higher the 
affinity for inserting into a membrane, and the higher hemolytic activity. Recall that increases in 
hydrophobicity are reported to result in increased helicity, and thus the increase in 
hydrohobicity of the hydrophobic face is, in my opinion, the actual cause for the increase in 
hemolytic activity. 
When helicity is a measure of the propensity for an AMP to interact with a membrane, it would 
be thinkable that the degree of helicity measured by CD could still be an accurate measure of 
how much peptide is actually folded into helix. However, this is not the case, based on our 
experiments. The low helicities measured by CD of these analogues (which were shown by NMR 
to have >90% helicity) indicates that a large part of the peptides does not bind to the micelles. 
The PRE data contradicts this, as the distance dependence of the PRE would cause such a high 
relaxation rate on all peptides not bound to micelles that the PRE differences between buried 
residues and exposed residues of the micelle bound peptides would vanish. 
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Structural impact of kinks in a helix 
When it has just been argued why helicity is not related to the actual helical structure of a 
peptide, then why are correlations found between helicity and hemolytic activity when 
disrupting the helical structure by the use of helix breaking residues? 
 
I believe that it is not the kink itself (i.e. a residue which does not obtain helical phi and psi 
angles) that reduces the hemolytic activity. It is rather the structural impact that follows from 
the kink, where some of the hydrophobic residues that used to be able to interact with the 
membrane interior are forced into another orientation by steric hindrances and lack of hydrogen 
bonds in the backbone. This way, the hydrophobic strength of the hydrophobic face will be 
reduced, and a lower membrane affinity results. This is probably the reason why a lower 
hemolytic activity is obtained. The measured reduction in helicity upon introduction of a kink can 
be caused by two things then: The kink residue will not contribute to the helical signal in the CD 
measurement and the lower membrane affinity can cause a reduction in the number of 
molecules adopting a helical configuration in the sample. 
 
The study by Shai and Oren of the cationic α-helical peptide TApar 
(GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE-(NH2)2) showed a gradual decrease in hemolytic activity 
upon reducing the helicity (measured in 40% TFE)47. However, this reduction of helicity was 
achieved by the substitution of Pro7, Leu18, and Leu19 with D-amino acids. These substitutions 
will break the helical structure, but the reduced hemolytic activity is probably a result of the 
structural changes around these substitutions, which prevents the hydrophobic residues from 
interacting with the membrane interior. Our data show that it is the strength of the interaction 
between the hydrophobic face and the membrane interior which determines the degree of 
hemolytic activity (Paper 1). In their study, they alter the direction of two of the most 
hydrophobic residues (Leu18 and Leu19) and/or introduced a kink between two pairs of very 
hydrophobic residues (LIPKII). A structural study of these analogues would show how much 
these changes displace the strongly hydrophobic residues, and would likely explain why a lower 
affinity (=lower hemolytic activity) for the membrane interior arises. In accordance with our 
results, the native TApar peptide is already too hydrophobic in order to exhibit a decent 
selectivity, and similar activity data as published by Zhai and Oren could likely be achieved by 
simply reducing hydrophobicity in the areas which were affected by the insertion of D-amino 
acids. Their insertion of D-amino acids yields a similar effect as we observed for 5K8W (paper 1), 
i.e. use of hydrophobic residues which are not able to interact with the membrane interior, and 
thus the resulting peptide retains a higher selectivity. 
A similar, but more comprehensive, study was made by Dathe et al. using the peptide 
KLALKLALKALKAAKLA-NH2 (KLAL)
48. Here, the amino acids were pairwise substituted from the N-
terminus with their D-analogues. It was found that the helicity (CD in 50%TFE) decreases the 
most when substituting in the middle of the sequence and that helicity correlates with dye 
release from neutrally charged large unilamellar vesicles (corresponding to their hemolytic 
activity). The introduction of the D-amino acids in the middle of the sequence will have a higher 
impact on the helical structure at the termini, and this is probably the reason that a lower 
hemolytic activity is observed for these analogues. The structural changes prevent some of the 
hydrophobic residues from interacting with the membrane interior, and a greater disruption 
(and thus reduction in the strength of the hydrophobic face) takes place when substituting in the 
middle of the sequence. This is in accordance with their own observations where they write “We 
suggest that double D-amino acid substitution modifies the size of the hydrophobic helix domain 
thus influencing hydrophobic peptide-lipid interactions” 48.  
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Furthermore their study also included a few analogues with reduced hydrophobicity (Leu to Ala 
substitutions). These analogues were found to exhibit lower hemolytic activity and reduced 
helicity as well. It is likely the strength of the hydrophobic face which again is the cause for the 
increased hemolytic activity. 
 
To conclude 
If a kink is introduced in an α-helical AMP, the resulting changes in side chain orientations will 
simply yield a smaller hydrophobic face, thus resulting in lower hemolytic activity. If the side 
chains were subsequently swapped around to allow for all hydrophobic side chains to again be 
directed towards the membrane interior, I believe that a basically unaltered hemolytic activity 
compared to the original AMP would be observed. Furthermore, reduction in hydrophobicity of 
the hydrophobic face is found to correlate with reduced hemolytic activity and helicity, which 
substantiates my hypothesis that helicities are most likely a measure of the peptide’s affinity for 
inserting into a membrane, which is dependent on the hydrophobicity of its hydrophobic face. 
Polar angle 
The polar angle/hydrophobic angle is not a structural parameter which in itself is related to an α-
helical AMPs activity. In a study such as Paper 1, the polar- or hydrophobic angle would be the 
same for all the conservative analogues, which display quite significant variations in both activity 
and selectivity. One could imagine that the experimentally determined polar angle might differ 
from analogue to analogue, but this was found not to be the case.  
Furthermore, the polar angle is a “dependent variable”, which means that the polar angle 
cannot be altered without also altering other (and more fundamental) properties of the peptide. 
 
The polar angle is a geometrical concept based on a projection of expected orientations of each 
residue in an α-helix. In my opinion, the fact that this is a projection is often forgotten or not 
considered very well. When looking at a helical wheel projection of a helical AMP and 
attempting to increase the polar angle, this is can be done by either non-conservative 
substitutions or rearranging the locations of the polar residues. This is best explained by 
examples. In Figure 10.1, a few helical wheel projections are given of peptides published by 
Dathe et al.3. 
 
Figure 10.12: Helical wheel projections of peptides published by Dathe et al. 
3
. KLA8, KLA9, and KLA10 were 
designed to be analogues which vary only in polar angle. Projections are made using the online service at: 
http://rzlab.ucr.edu/scripts/wheel/wheel.cgi. 
Note:  KLA8, KLA9, and KLA10 were designed by Dathe et al. to be identical in respect to hydrophobicity and nearly 
identical in respect to hydrophobic moment (reported hydrophobic moments were 0.291, 0.295, and 0.299, 
respectively).  They all consist of the exact same amount of amino acids 6 Ala, 6 Leu, 1 Trp, and 5 Lys, and were 
designed in order to compare the effect of increasing the polar angle as an isolated parameter. From the helical 
wheel projections shown here, it is obvious that KLA9 cannot have a similar hydrophobic moment to that of KLA8 
and KLA10. The size and direction of the hydrophobic moment is actually given in the center of each projection. The 
hydrophobic moments reported in the article are thus erroneous. 
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Non-conservative substitutions 
The polar angle is extended either with a continuous polar face, or with a polar face with apolar 
residues in between. From KLA1 (in Figure 10.1), an increase in a continuous polar angle would 
result from substituting L8 or L2 with a polar amino acid, whereas a polar angle with 
hydrophobic residues in between would result from substituting L15 or A13 with a polar residue. 
Of course, this is under the assumption that the helical wheel projection is in agreement with 
the actual helical structure of the peptide. 
These alterations are actually not just an increase in polar angle, but also an increase in polarity 
of the hydrophilic face and a reduction of the hydrophobicity of the hydrophobic face of the 
helix. I believe that the two latter are the actual cause for changes in activity, and not the 
increased polar angle as such. 
 
Rearrangement of residues 
Examples of how the polar angle is increased by rearranging the polar residues can be seen from 
KLA8, KLA9, and KLA10 compared with KLA1. The problem of this type of modification is that it 
looks fine on the helical wheel projection, but in fact, this type of modification drastically alters 
the amphipathicity of each turn of the helix. Both KLA8 and KLA10 are left with one turn devoid 
of polar residues, creating a very hydrophobic segment (which makes it highly attracted to all 
membranes), while KLA9 has two very strongly hydrophobic residues oriented towards the bulk 
water (assuming that the peptide adapts a helical structure and inserts itself into a membrane 
with the polar residues oriented out of the membrane). I am actually not convinced that KLA9 
will actually fold into a regular α-helix, as Ala does not have a high affinity for a membrane 
interior, whereas Leu does. I believe that this analogue would be more or less unstructured, as 
this will allow for the highly hydrophobic residues to interact with the membrane interior. This is 
supported in part by their helicity measurements, where KLA9 has the lowest degree of helicity 
of all the KLA analogues in that paper. Keep in mind that helicity measurements in TFE does not 
show whether a helix will actually be formed upon membrane interaction. 
KLA8, KLA9, and KLA10 all show about a factor of 5 higher hemolytic activities than KLA1, while 
only altering the antimicrobial activity with about a factor of 2. According to our theories, this 
increase in hemolysis should be caused by a stronger interaction of the hydrophobic face of the 
peptide with the membrane interior. This is easily explained for KLA8 and KLA10 due to the turn 
without hydrophilic residues and due to the highly hydrophobic residues being directed towards 
the membrane interior (in KLA1, the Ala residues are directed towards the membrane interior 
and the Leu residues towards the interface between membrane and solvent, according to the 
projections). For KLA9, a stronger interaction of the Leu residues with the membrane interior 
would be possible if a regular helix is not formed, but experimental data is needed to conclude 
on this. In the work of Dathe et al., it was pointed out (and included in the abstract) that a polar 
angle above 80˚ was associated with a significant increase in hemolytic activity, which I believe is 
a misinterpretation for the reasons explained above. 
 
To conclude 
Our results from Paper 1 and the principles exemplified from literature clearly show that the 
polar angle is not a parameter which can be used in SAR studies. It is rather a phenotype which 
can result from several types of modifications of the peptides. 
Even if people do not agree with these points, we have already shown in paper 1 and 2 that the 
side chain orientations are not in complete agreement with the helical wheel model, and that 
the helix of longer peptides can be extended (and maybe compressed) depending on the 
sequences. Thus, polar angles calculated based on the helical wheel model are not necessarily in 
accordance with the actual structure of the peptides.   
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11. Conclusion 
The SAR derived from the anoplin study 
The relationship between the activity of a cationic helical AMP and its structure is surprisingly 
simple, considering the variety of parameters used in the literature so far. In order to increase 
the general membrane affinity of an AMP, the hydrophobicity of its hydrophobic face should 
simply be increased. This will, however, be an unbiased increase in membrane affinity, and after 
crossing a peptide-length dependent threshold value, further increases in hydrophobicity will 
quickly cause the loss of selectivity towards bacterial membranes. This knowledge also gives the 
answer on how to increase the selectivity of an already highly hemolytic helical AMP: reduce the 
hydrophobicity of its hydrophobic face (within reason). This will always increase the selectivity 
for highly hemolytic helical AMPs. In order to increase the activity of a cationic helical AMP in 
selective manner, the focus should be on the hydrophilic face of the helix. We have 
demonstrated in paper 1 that there should be a distinction between the residues oriented such 
that their side chains cannot interact with the membrane interior and the residues which are in 
the interface between the membrane interior and the surrounding solvent. It was shown that 
increasing the polarity (which includes the addition of charge) will for both types create 
analogues with higher antibacterial activities. For some analogues, this increase in activity was 
followed by an equal increase in hemolytic activity, thus maintaining the selectivity. However, 
due to low hemolytic activities, it could not be seen if all increases in charge are followed by an 
equal increase in hemolytic activity or if an increase in activity can be achieved without an 
increase in hemolytic activity.   
The simple “to do” is thus: First trim the hydrophobicity of the hydrophobic face until hemolysis 
is at an acceptable level, and then increase the polarity of the hydrophilic face until further 
increases cannot increase the antibacterial activity any further. 
Although this very simple SAR exists for the cationic helical AMPs, there are various other ways 
to alter the sequence (and in some cases structure as well) of these AMPs. One can use 
hydrophobic residues on the hydrophilic face, polar or charged residues on the hydrophobic 
face, replace a given residue with its D-amino acid counterpart or peptoid counterpart, or even 
use a mixture of these types of changes. Further research is still needed to answer on how all 
these kinds of changes will influence the activity and selectivity of the cationic helical AMPs.  
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12. Perspectives 
AMP testing in the future 
The use of the MIC assay in evaluating the potency of AMPs is in principle a good way to 
evaluate the effect of given substitutions compared to the initial AMP lead structure. However, 
many of the studies presented in literature evaluate the antimicrobial activity at peptide 
concentration increments of a factor of 2 or more. This brings about a great deal of uncertainty 
of how big a change in activity is actually achieved by a given substitution. As an example, AMP1 
has an actual MIC of 95μM and AMP2 has an actual MIC of 105μM. If tested in a factor 2 dilution 
series starting at 200μM, AMP1 would be measured with a MIC of 50μM and AMP2 would be 
measured with a MIC of 100μM. They are thus observed to have a factor 2 difference in activity, 
despite that the actual difference is only a factor of 1.1. It is important for this type of studies to 
use small increments in peptide concentration in the MIC assay, and this becomes very essential 
in the structure activity relationship studies where the structural changes are very small. 
 
In newer literature, a higher degree of consensus regarding the parameters which are important 
for AMP activity and selectivity is found53, but despite promising in vitro experiments it is still 
uncertain whether these compounds are of any use in vivo. After spending 3 years on SAR 
studies, I cannot help but pondering about the usefulness of the MIC and hemolysis assay in 
relation to evaluating AMPs as potential antibiotics. For some of my compounds the selectivity 
(EC50/MIC) reaches a factor of 80, but is this enough? What is a good selectivity? Upon 
administration of a drug, the local concentration should never reach a toxic level, and in my 
opinion, even 5-10% hemolysis is pretty bad. The gap between the MIC and the concentration at 
which no hemolysis is observed is significantly less than the calculated selectivity. Furthermore, 
the fact that hemolysis actually does occur at high concentrations of a given AMP indicates that 
the AMP has some affinity for the mammalian cells, which will cause adsorption of the AMP to 
non-bacterial cells and thus reducing the effective concentration of that AMP.  
It is in my opinion essential that we develop new methods for routine testing of AMP usefulness. 
The most straightforward approach to evaluating the MIC and selectivity of an AMP in vivo is to 
better mimic the conditions of an infection in the blood. By performing the MIC testing in the 
presence of human blood cells, the adsorption of AMP to the mammalian cells will be taken into 
account in the determination of the MIC value. Furthermore, by using a microscope technique to 
monitor the growth of bacterial cells as well as the destruction of the erythrocytes, it will be 
possible to measure whether a MIC concentration without significant side effects can be 
obtained. This would give a reasonable guideline for which AMPs are selective enough to be 
considered potential for drug development. The current developments with the oCelloScope, 
already makes such a combined assay technically possible. 
This does, however, not take into consideration the rate of degradation of AMP, which is 
essential according to our experiments. They show that the anoplin analogues should be present 
at a concentration above the effective MIC for more than 2 hours before killing of bacterial cells 
is initiated, and for more than 4 hours for effective killing of bacterial cells (dilution of our 
peptide to below MIC after 4 hours of incubation allowed for bacterial cells to continue growth). 
The inclusion of host AMP degradation in an in vitro experiment would be a huge improvement 
in a MIC assay. 
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If these changes could be implemented in the routine testing of AMPs, I believe this would give a 
rather realistic evaluation of the usefulness of an AMP for combatting bacterial infections in the 
blood by intravenous administration. However, it will not be possible to extrapolate these 
results to infections in tissues or by other means of administration, as the transport of AMP to 
the bacterial cells becomes much more complex. 
Future experimental designs 
During the work performed in this Ph.D. study, I came across a lot of questions regarding AMP 
structure-activity relationships which I could not answer based on the set of peptides which 
were produced and tested in the project. In order to answer these questions, a series of smaller 
studies should be performed, which I present in this section. 
Bending of side chains 
From the set of anoplin analogues containing Trp, the structural studies showed a bending of the 
side chain of the Trp residue for 5W and 5F8W (the ones which places Trp as an extension of the 
hydrophobic face), but not for 5K8W (Trp inserted instead of a solvent interacting residue). 
These analogues were the onset for thinking that there are two types of polar residues in an 
amphipathic helical AMP. However, the bending is very significant for a Trp residue, as the 
orientation of the asymmetric indole moiety is highly influential on the direction to the 
geometric mean of the side chain. It is uncertain whether an equally significant bending will be 
observed when using for instance a Leu residue. The data from our study are unambiguous, but 
the results are still obtained from a very small set of peptides, and only by using Trp as the 
hydrophobic residue. In order to validate our findings, a more extensive study which includes a 
more symmetric hydrophobic side chain should be performed. For this study I propose the use 
of 5,8K as the reference compound in which Trp and Leu are systematically inserted instead of 
the Lys residues to investigate the structural behavior in all positions occupied by a polar residue 
in the wild type anoplin.  
Reference compound Trp series Leu series 
GLLKKIKKLL-NH2 
(anoplin 5,8K) 
 
GLLWKIKKLL-NH2 
GLLKWIKKLL-NH2 
GLLKKIWKLL-NH2 
GLLKKIKWLL-NH2 
GLLLKIKKLL-NH2 
GLLKLIKKLL-NH2 
GLLKKILKLL-NH2 
GLLKKIKLLL-NH2 
Lipid head group interacting versus a water interacting residues 
It was observed that inserting the Trp residue as an extension of the hydrophobic face of anoplin 
(5W) was detrimental to the selectivity of these analogues due to a very large rise in hemolytic 
activity. However, insertion of the Trp residue instead of a solvent exposed residue (5K8W) was 
less detrimental to the selectivity due to a lower rise in hemolytic activity. However, the 
resulting analogues also varied significantly in mean hydrophobicity which prevents a conclusive 
answer to why the insertion of Trp in position 8 is less detrimental to the selectivity. In extension 
to the “Bending of side chain” study, the analogues should be tested for antimicrobial and 
hemolytic activity to verify that there is a difference in selectivity between inserting a 
hydrophobic residue instead of a lipid head group interacting and instead of a solvent oriented 
residue. However, the reference compound (5,8K) has an EC50 of above 500μM, which makes it 
impossible to estimate how much the selectivity is affected, despite it will be easily observed 
which analogues will be most hemolytic. To quantify the loss in selectivity, a slightly more 
hemolytic analogue should be used as reference, such as 2,10Hle5,8K, which was found to have 
an EC50 below 500μM. 
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Reference compound Trp series Leu series 
G-Hle-LKKIKKL-Hle-NH2 
(2,10Hle5,8K) 
 
G-Hle-LWKIKKL-Hle-NH2 
G-Hle-LKWIKKL-Hle-NH2 
G-Hle-LKKIWKL-Hle-NH2 
G-Hle-LKKIKWL-Hle-NH2 
G-Hle-LLKIKKL-Hle-NH2 
G-Hle-LKLIKKL-Hle-NH2 
G-Hle-LKKILKL-Hle-NH2 
G-Hle-LKKIKLL-Hle-NH2 
 
The role of Gly and Ala in AMPs 
For longer peptides, Gly and Ala become more prevalent. They are often found on the polar face 
or at the the interface between the hydrophobic and polar face. In the study of Ifrah et al., the 
Ala scan of anoplin showed that antimicrobial activity and hemolytic activity was increased when 
inserting Ala instead of the polar residues 5, 7, and 8, but not upon substitution of polar residue 
4 28. I believe that Ala mainly plays a role as an interface residue, which contributes only little to 
the strength of the hydrophobic face, whereas Gly does not contribute to the strength of the 
hydrophobic face at all. Gly is in my opinion used on the polar face as a “neutral” residue in 
order to reduce charge repulsion between the charged side chains – in other words: just a filling 
residue.  
In order to confirm these thoughts, I would perform an Ala scan and Gly scan only on the polar 
residues while using 5,8K as the reference compound. The results from the Ala scan would help 
in validating whether there are two different types of polar residues, as well as being useful for 
estimating how much Ala actually contributes to the strength of the hydrophobic face. The Gly 
scan would be useful for estimating whether Gly can actually contribute to the strength of the 
hydrophobic face, and estimate the importance of charge in each of the polar positions. 
Reference compound Ala series Gly series 
GLLKKIKKLL-NH2 
(anoplin 5,8K) 
 
GLLAKIKKLL-NH2 
GLLKAIKKLL-NH2 
GLLKKIAKLL-NH2 
GLLKKIKALL-NH2 
GLLGKIKKLL-NH2 
GLLKGIKKLL-NH2 
GLLKKIGKLL-NH2 
GLLKKIKGLL-NH2 
 
Rotation of a helical AMP 
In our study we observed rotation of anoplin around the helical wheel axis with respect to the 
micelle surface when double substituting with hydrophobic residues. In our experiments, these 
were highly hydrophobic residues, and the equal “pull” towards the micelle interior of all 
residues makes rotation and the observed amount of rotation highly plausible. However, in 
many AMPs the distribution of hydrophobic residues is not as symmetric as in anoplin. Thus, it 
would be beneficial to see how much the rotation depends on the hydrophobic strength of the 
hydrophobic residues. Furthermore, it would be interesting to know if this rotation can take 
place in both directions, and whether the terminal groups influence the ability to rotate. As a 
preliminary study, I propose to structurally study two types of double substitutions in anoplin 
(4,7X and 5,8X as shown in Figure 12.1) by using either Leu, Val, or Ala for each analogue. By 
using Leu, it will be possible to see if the helix has an equal propensity for rotation in both 
directions when all the hydrophobic residues have an equal hydrophobicity. By using Val and 
Ala, it will be possible to see how the magnitude of hydrophobicity influences the degree of 
rotation. 
Reference compound Leu series Ala series Gly series 
GLLKKIKKLL-NH2 
(anoplin 5,8K) 
GLLKLIKLLL-NH2 
GLLLKILKLL-NH2 
GLLKAIKALL-NH2 
GLLAKIAKLL-NH2 
GLLKGIKGLL-NH2 
GLLGKIGKLL-NH2 
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Figure 12.1: Helical wheel plots, illustrating the locations of the double substitutions used in the experiments to 
investigate rotation of the helix compared to the reference compound. Hydrophobic residues are in blue, 
hydrophilic residues in red, and substitution sites in green.  
The knowledge obtained from the Gly and Ala substitution series as well as these rotation 
studies will provide crucial information regarding whether to replace an Ala and Gly residue in 
an AMP with a polar or hydrophobic residue when modulating the activity. Furthermore, this will 
probably enable one to predict the results from Ala scan experiments, thus rendering these 
experiments unnecessary in the future. 
 
Site of insertion of a lipophilic anchor 
The results of my studies where Cha was inserted at different locations in anoplin showed a 
tendency that the site of insertion influenced the antimicrobial and hemolytic activities in 
different ways. This was estimated to be within experimental error, and thus nothing could be 
concluded on the basis of these data. However, the studies of Munk et al. and Slootweg et al. 
showed similar results, where the MIC and EC50 are dependent on the site of Leu to X 
substitution54,55. The study of Munk et al. was however designed with very large increments in 
peptide concentrations in the MIC assay (jumps with a factor of 3), which makes it uncertain 
how big the difference in MIC actually is while the study of Slootweg et al. was based on a small 
subset of peptides. 
 
Thus, in order to answer whether the site of insertion really does play a significant role in the 
antimicrobial and hemolytic activity, a more systematic study should be performed. I suggest to 
increase hydrophobicity of each of the hydrophobic residues in turn, using e.g. Hle, Epa, Phe, 
Cha, and (S)-2-aminoundecanoic acid (the lipophilic anchor used by Slootweg et al.54). Further 
choices of side chains with increasing hydrophobicity can of course be included.  
 
Reference compound Substitution series Suggested residues 
GLLKKIKKLL-NH2 
(anoplin 5,8K) 
 
GXLKKIKKLL-NH2 
GLXKKIKKLL-NH2 
GLLKKXKKLL-NH2 
GLLKKIKKXL-NH2 
GLLKKIKKLX-NH2 
Hle 
Epa 
Phe 
Cha 
(S)-2-aminoundecanoic acid 
Anoplin is an excellent model peptide for an initial study on hydrophobic anchors, but due to its 
very short length a large change in hydrophobicity in one position becomes very influential for 
the whole peptide. This will make the findings from a study on anoplin very hard to extrapolate 
to longer peptides. Thus, this type of study should also be performed on a peptide of a 
significant length to distinguish between an increase in hydrophobicity at a terminal, near a 
terminal, and in the middle of an AMP. The choice of AMP should be one which shows only a 
slight degree of hemolysis in the reference sequence, as all increases in side chain 
hydrophobicity will increase the hemolytic activity and the propensity for self-aggregation. 
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Maculatin-G15 studies with inclusion of peptoid monomers 
 
Figure 12.2: Experimentally derived helical wheel of maculatin-G15 (GLFGVLAKVAAHVVGAIAEHF-NH2). 
Is trans in general the most favorable conformer? 
From the structural studies of maculatin-G15 analogues with a peptoid monomer (Nleu) 
substituted into position 9, 10, 11, and 13 showed that upon insertion of the analogue into a 
micelle, only one conformer was observed for M-Nleu10 and M-Nleu11 (trans for M-Nleu-11 and 
unknown for M-Nleu10), while the trans and cis conformers were almost equally favorable for 
M-Nleu9 and M-Nleu13. The cause for this is puzzling to me. Could it be that the trans 
conformer in general is more favorable than the cis conformer (perhaps due to the differences in 
backbone folding), but that the trans conformer always directs the Nleu side chain significantly 
counter-clockwise (>100˚) in the helix relative to an amino acid side chain, as seen for M-
Nleu11? If this is the case, the trans conformer of M-Nleu9 and M-Nleu13 would have the Nleu 
side chain directed towards the lipid head groups or solvent surrounding the micelle. This would 
be energetically unfavorable, thus making it relatively more favorable to adopt the cis 
conformation. This could be the explanation for the presence of both cis and trans conformers 
for these two analogues. 
Before trying to prove this hypothesis, it should however be tested if this is a general trend, and 
not just a coincidence within this small subset of analogues. In order to test whether there is a 
trend is to expand the set of analogues with a Nleu residue inserted. My suggestions for the sites 
of substitution are marked by underline and bold in the maculatin-G15 sequence: 
GLFGVLAKVAAHVVGAIAEHF-NH2 
 
It is important to notice that the insertion of the peptoid monomer close to the terminals of the 
peptide increases the risk that a helical secondary structure will not be formed on both sides of 
the peptoid monomer, and that the smaller segment might not be amphipathic enough to insert 
itself into the micelle. However, if helical structure and insertion into micelle is obtained for both 
ends of the analogues, a larger set and variety of peptoid monomer orientations can be tested 
for prevalence of the cis and trans conformer. From Figure 12.2, it can be seen that residues 5, 6, 
and 7 are oriented similarly to residues 16, 17, and 18, and significantly different from the 
already investigated analogues (residues 9, 10, 11, and 13). 
A different approach for testing whether a general trend for trans being the most favorable 
conformer is observed is to use a charged peptoid monomer such as Nlys (peptoid monomer 
with side chain identical to that of Lys) in the same positions as were tested with the Nleu 
residue. This would invert the side chain properties and should thus make the trans conformer 
unfavorable for positions 10 and 11, while making it favorable for positions 9 and 13. The benefit 
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of this approach is that the two helical segments surrounding the peptoid monomer will be 
formed (although the degree of helix breaking can vary from what has been observed in our 
studies). Of course, the set of analogues with this polar peptoid monomer can be expanded to all 
the sites suggested for Nleu. 
NMR is a fast method for determining the distribution of the cis and trans conformers of the 
various analogues. A quick estimation of the amount of spin systems in the TOCSY spectrum 
reveals whether one or two conformers are present, and after assignment of residues to the 
different spin systems, the NOESY spectrum reveals whether it is the cis or trans conformer. The 
distinction is based on the presence of NOEs from the Hα of the residue preceding the peptoid 
monomer to the backbone or the side chain of the peptoid monomer. This is relatively easy to 
perform, compared to calculating the actual structure for each analogue, thus making this a 
worthwhile study to perform. 
Further characterization of the maculatin peptide/peptoid hybrids 
The study of the maculatin analogues in this work has solely been focusing on structural 
characterization. Thus, other properties of these analogues have not been investigated, which 
leaves unanswered questions regarding especially the activity (MIC and EC50) and proteolytic 
stability. 
 
MIC and EC50 study 
When studying how the insertion of the Nleu peptoid monomer influences the activity of the 
AMP, it is highly interesting to notice whether the presence of one or two conformers 
significantly changes the activity and selectivity. It would be highly interesting to compare M-
Nleu13 with M-Nleu14 (both are Val to Nleu substitutions), as these analogues have the same 
overall properties but are expected to have different conformer distributions. M-Nleu13 has 
already been shown to adopt two conformers, and residue 14 is oriented between the residues 
10 and 11 which only adopted one conformer. 
 
Proteolytic stability study 
It is well known that the insertion of a peptoid monomer increases the proteolytic resistance of 
an AMP, but it is not well described how this increase in proteolytic resistance is influenced by 
the length of the AMP, the site of insertion of the peptoid monomer, and the number of inserted 
peptoid monomers. For such a long AMP, it is likely that the proteolytic resistance is only slightly 
increased upon insertion of a peptoid monomer at one of the ends of the AMP, as a major part 
of the helix will be unaffected by this substitution. 
The measurements of the proteolytic stability of these hybrid compounds should be done both 
in an aqueous environment and in a sample where interaction with lipid micelles is possible. 
Depending on the membrane affinity for a given compound, the different conditions can yield 
very different degradation rates. Finally, it would be highly interesting to relate the presence of 
one or two conformers with the proteolytic resistance of the AMPs in order to evaluate what is 
most favorable. 
 
From all of these studies, the hope is to be able to formulate a set of guidelines on where to 
insert hydrophobic and polar peptoid monomers in order to modulate the activity and selectivity 
of the AMP while increasing the proteolytic stability as much as possible. 
Prospects for using PRE in future research 
As shown in paper 1, the use of PRE to derive distance restraints was of high importance for 
analogues which were non-conservatively modified, as it showed how the orientation of side 
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chains and peptide as a whole changed. For the conservative substitutions, only slight changes in 
insertion depth were observed, and for conservative changes on the hydrophobic face, these 
insertion depth changes did not correlate well with the activity of the analogues. In my opinion 
this demonstrates that PRE derived distance restraints are not useful for deriving SAR 
parameters. However, PRE is highly beneficial to use on the lead compound of interest in order 
to characterize its orientation and to classify its residues (solvent interacting, lipid head group 
interacting, or membrane interior interacting). This knowledge is very important for rationally 
designing improved analogues, and an important benefit from using PRE. 
The perhaps largest strength in our use of PRE is its ability to yield structural information of 
unstructured membrane interacting peptides and peptide segments. For unstructured segments, 
this technique will yield information on which residues are embedded into the membrane and 
which are exposed to the solvent. This knowledge will assist in understanding how these AMPs 
are bound to the membrane and which requirements to their sequence that must be fulfilled in 
order for this membrane binding to take place (if any requirements exists). 
Many α-helical AMPs contain a Pro residue in their sequence which is generally believed to 
cause a kink in the helix. Kinks are also expected upon insertion of D-amino acids or peptoid 
monomers, which are primarily done in order to increase proteolytic resistance of the AMP of 
focus. As demonstrated in our work on maculatin analogues with an embedded peptoid 
monomer, PRE derived distance constraints are essential for determining the global orientation 
of the two segments which are separated by a kink. This even provided an explanation of why 
only the trans conformer was found for M-Nleu11. Thus, PRE is of great potential in structural 
studies of membrane interacting peptides with kinks or structurally undefined middle regions.  
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